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ABSTRACT 
Background: Chronic kidney disease (CKD) is a global health problem. The most common etiologies 
of CKD are diabetes mellitus, hypertension, and glomerulonephritis, but over the last several decades 
a high prevalence of CKD of unknown etiology (CKDu) has been reported from rural communities in 
some tropical countries, including Central America, and Sri Lanka. The CKDu endemics share some 
mutual characteristics, they usually affect rural communities and men are more often affected than 
women. In Central America, the disease often affects male sugarcane workers. In Sri Lanka, male rice 
farmers in certain areas are at risk of developing CKDu. The cause or causes behind the CKDu 
endemics have not been elucidated. Furthermore, it has not been determined whether the two 
endemics are similar diagnostic entities. Kidney biopsy is an important tool to evaluate CKD, but in 
Central America, biopsy studies from patients with CKDu were lacking at the beginning of our 
studies.                                                                                                                                                  
Aim: The aims were to describe the renal morphology and biochemical characteristics in patients with 
CKDu in Central America and Sri Lanka in order to find pathogenetic mechanisms, to study the 
natural history of the disease, and to compare the endemics to determine if they are related diagnostic 
entities.                                                                                                                                             
Material and Methods: Patients with CKDu were evaluated with kidney biopsy, biochemical tests 
and a questionnaire. Light- and electron microscopy as well as immunofluorescence evaluation were 
performed on the biopsies. Follow-up blood and urine samples were collected from subjects in Studies 
I and II after 1-2.5 years.                                                                                                                       
Study I: Eight male agricultural workers in El Salvador with an estimated glomerular filtration rate 
(eGFR) between 27-79 ml/min/1.73m² were included. The kidney biopsies showed a unique renal 
morphology with extensive glomerulosclerosis, signs of glomerular ischemia, mild to moderate 
tubular atrophy, and interstitial fibrosis. Vascular structures were generally only mildly changed. In 
serum, low potassium levels were a common finding.                          
Study II: Nineteen males from Nicaragua with a history of sugarcane work were included. eGFR was 
between 33-96 ml/min/1.73m² and low serum sodium, potassium, and magnesium were frequent 
findings. Sixteen biopsies were representative and the morphology displayed chronic glomerular 
changes with glomerulosclerosis, glomerular hypertrophy, and signs of glomerular ischemia. Mild to 
moderate tubulointerstitial changes and mostly mild vascular changes were found. Follow-up samples 
from 7 participants from Study I and 18 participants from Study II showed a mean eGFR change of     
-4.4 ± 8.4 ml/min/1.73m² per year.                 
Study III: Eleven male rice farmers from Sri Lanka with an eGFR between 21-70 ml/min/1.73m² 
were included. Again, low sodium, potassium, and magnesium were common. The main biopsy 
findings were chronic glomerular changes (glomerulosclerosis, glomerular hypertrophy) and mild to 
moderate tubulointerstitial changes. Vascular changes were in most cases mild but in a few cases 
moderate. The biopsies showed a more mixed morphology compared to Studies I and II. Interstitial 
inflammation and vascular pathology were more frequent.                                                                                 
Conclusions: Studies I and II show that CKDu in Central America is a unique diagnostic entity with a 
renal morphology characterized by chronic damage in both glomerular and tubulointerstitial 
compartments. Although Study III in Sri Lanka revealed a more mixed kidney biopsy morphology, 
the majority of the subjects had a morphology quite similar to the findings in Central America. Low 
levels of serum electrolytes were a typical finding in all studies. In summary, CKDu in Sri Lanka and 
Central America have more similarities than differences in both the morphological and the 
biochemical characteristics, which supports the theory that the endemics have a common etiology.   
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1 BACKGROUND 
1.1 STRUCTURE AND FUNCTION OF THE KIDNEY 
The kidneys are paired organs located retroperitoneal in the abdomen, with an average size of 10-13 
cm and weight of 150 g each. The kidney tissue consists of cortex and medulla and is surrounded by a 
fibrous capsule (Figure 1). Blood enters the kidneys via the renal artery with 20-25% of the cardiac 
output provided to the kidneys, i.e. renal blood flow is approximately 1-1.25 L/min (1).  
The primary function of the kidneys 
is to produce urine and thereby 
regulate the volume of fluid in the 
body, regulate electrolyte and 
acid/base balance, and dispose of 
metabolic end products. The 
functional unit of the kidney is the 
nephron composed of the 
glomerulus, Bowman’s capsule, and 
the tubular system ending in the 
collecting duct (Figure 2a). Around 
one million nephrons are found in 
each kidney.  
The glomerulus is a round structure 
consisting of small capillaries which are lined by endothelial cells on the inner surface and 
specialized epithelial cells called podocytes on the outer surface (Figure 2b). The capillary loops in the 
glomerulus are held together by mesangial cells and matrix. Blood enters through the afferent 
arteriole, and is subsequently filtered through the filtration barrier of the capillaries (endothelium,  
                        
 
 
 
 
 
 
 
 
Figure 1: Anatomy of the kidney.                                                                     
Image by Blausen.com staff (2014)/Wikimedia. 
Figure 2a: Nephron structure. Image by Holly Fisher/Wikipedia commons. Figure 2b: Cross section of a glomerulus. AA, 
afferent arteriole; D, distal tubule; E, endothelial cell; EA, efferent arteriole; F, podocyte foot process; G, juxtaglomerular cell; 
GBM, glomerular basement membrane; M, mesangial cell; MD, macula densa; P, proximal tubule; PE, parietal epithelial cell; 
PO, podocyte; US, urinary space. Modified from National Kidney Foundation’s Primer on Kidney disease 2014 (edt. Gilbert 
and Weiner).  
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glomerular basement membrane and the podocyte slits). An ultrafiltrate (primary urine) is produced 
and collected by the surrounding Bowman’s capsule. The remaining blood exits the glomerulus 
through the efferent arteriole. Large compounds in the blood such as larger proteins  (>60-70 kDa) 
and blood cells are too big to be filtered and are normally not found in the filtrate (1). Approximately 
180 L of filtrate is produced per day. The filtrate is transported and modified through the tubular 
system to be transformed into the final urine. The vast majority of the filtrate is reabsorbed in the 
tubules and the final urine output is 1.5-2 L/day. Throughout the tubular structure, various solutes 
including glucose, electrolytes (sodium, potassium, calcium etc.), amino acids, proteins, vitamins, 
hydrogen ions, and urea are reabsorbed and secreted (2). The glomerular and tubular structures in 
kidney tissue can be examined by light microscopy and electron microscopy (Figure 3a and 3b).   
 
     
Figure 3a: Light microscopy image of a normal glomerulus. Figure 3b: Electron microscopy image of a normal glomerulus.   
Glomerular filtration rate (GFR) is a measurement of the kidney function; specifically it is an 
estimation of how much blood that is filtered in the glomeruli per minute. GFR is normally ≥ 90 
ml/min/1.73m² in healthy individuals. Normal ageing causes a decline in GFR between 0.4-1.2 
ml/min/1.73m² per year in adults (3). Many kidney diseases cause a permanent and sometimes 
progressive decline in GFR. The golden standard of measuring GFR is by analyzing the plasma 
concentration and excretion (renal clearance) of Inulin, a molecule that is freely filtered through the 
glomerulus and is not absorbed/excreted in the tubules. However, the method is cumbersome to 
perform and therefore in practical settings as in hospitals and in most research studies, an estimation 
of the GFR (eGFR) is made by using an equation including serum creatinine and/or serum Cystatin C.  
In addition to producing urine, the kidney has other important functions (1):  
 Regulating blood pressure and salt balance by excretion of renin from the juxtaglomerular 
cells in the glomeruli, thus activating the Renin–Angiotensin–Aldosterone System 
(RAAS). 
 Stimulating the maturation of red blood cells by excretion of erythropoietin from 
interstitial cells in the cortex.  
 Conversion of 25-(OH) vitamin D into the active vitamin D form 1,25 dihydroxy-vitamin 
D, which is important for the calcium homeostasis.       
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1.2 CHRONIC KIDNEY DISEASE 
Chronic kidney disease (CKD), defined as eGFR <60 ml/min/1.73m², is a serious and increasing 
health problem worldwide, with a prevalence of around 4.7-8.1% in Europe (4, 5), 4.5-7.7% in the 
US (6) and 8-16% globally (7, 8). In the “Global burden of diseases” study published in 2010, the 
age-standardized death rate from CKD actually increased from 1990 to 2010 in contrast to most 
other diseases (e.g. major cardiovascular disease and most cancer diagnoses) for which death rates 
fell during this time period (9). CKD affects populations in low-, middle-, and high-income 
countries, but with somewhat different spectra of causes. Diabetes and hypertension are the two 
most common CKD causes in most middle- and high-income countries, while glomerulonephritis 
and unknown causes are more frequent in low-income countries and parts of Asia (8). 
CKD may progress to end-stage renal disease (ESRD), a state where the patient needs renal 
replacement therapy (RRT), i.e. dialysis or kidney transplantation, for survival. RRTs are costly 
treatments that often are associated with adverse events such as infections, malignancies, increased 
mortality rates and reduced quality of life (10, 11). However, even if the CKD does not progress to 
ESRD, the chronic condition of CKD has been identified as a major independent risk factor for 
morbidity and mortality, especially with regard to cardiovascular disease (12, 13).  
In recent years, a remarkably high prevalence of chronic kidney disease of unknown etiology (CKDu) 
has been reported from several low- and middle-income regions, including Central America, Sri 
Lanka, India, and Egypt (14). 
 
1.3 CKDu IN CENTRAL AMERICA - MESOAMERICAN NEPHROPATHY 
 
 
 
Figure 4: Map of Central America.                                                          
Source, Map Data ©2017 Google, INEGI.  
 
 
 
 
1.3.1 Overview 
Mesoamerican nephropathy (MeN) is the name of the endemic form of CKDu affecting mainly male 
rural agricultural workers living along the pacific (west) coast line of Central America (15) (Figure 4). 
A high prevalence of CKD in certain areas of Central America has been observed by local physicians 
and media for several decades but the first scientific report was published in 2002, describing a group 
of 205 patients with newly diagnosed ESRD. This study concluded that the majority of the patients 
with ESRD had CKDu, i.e. their disease was not correlated to traditional causes and risk factors for 
CKD such as hypertension, glomerulonephritis, or diabetes mellitus (16).  
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Men working with sugarcane cultivation in regions close to the Pacific coast seem to be at greatest 
risk of developing the disease (17), but women and other agricultural workers and manual laborers in 
these areas are also affected. Nicaragua and El Salvador are the countries in the region with most 
reported CKD cases and the highest mortality rate due to CKD (18). In some areas up to 19-40% of 
the male and 5-14% of the female inhabitants have CKD with eGFR <60 ml/min/1.73m² (19-23). In 
Central America, where health resources are limited, the diagnosis of CKD can be devastating. Many 
people with MeN die of ESRD because dialysis treatment facilities are insufficient and there are no 
functioning kidney transplant programs. In Nicaragua, the sugarcane community La Isla, where the 
mortality among men due to CKD is very high, is now locally called “La Isla de Viudas”, i.e. the 
Island of Widows (24).  
People working in the sugarcane fields work under extreme conditions during the harvest season from 
mid-November to the end of May. The sugarcane fields are often burned the day before harvest to 
remove the leafy material of the sugarcane plant. When the sugarcane workers start to harvest there 
could still be some heat left in the ground. Work is conducted under direct sunlight and the mean daily 
temperature during harvest season in Central America is 27-30°C, with temperatures during the 
daytime usually reaching highs of 32-35°C. A sugarcane cutter is usually paid based on performance, 
and several tons of sugarcane are harvested manually with a machete every day (Figure 5). Working 
hours are usually from early morning until midday, however, the combination of temperature and 
workload puts the workers at risk for work-related heat stress already between 9:00 a.m. and 10:00 
a.m. (25).  
 
   
Figure 5: Sugarcane cutters in El Salvador harvesting sugarcane manually with a machete. Photos courtesy of Tom Laffay 
for La Isla Network.  
1.3.2 Prevalence studies 
Even though there are no completely reliable numbers for the full extent of the epidemic in Central 
America, local nephrologists and health care workers have reported a steady increase of patients with 
CKD during the last decades that is overwhelming the health care facilities in the affected regions. 
According to the World Health Organization (WHO), kidney disease is the third most common cause 
of death in Nicaragua and the fifth most common health related cause of death in El Salvador (26, 27).  
Several local and governmental reports from the 1990s to 2005 have described the rising number of 
patients with CKD in Central America. In November 2005 a workshop by the Program on Work and 
Health in Central America (SALTRA), funded by the Swedish International Development 
Cooperation Agency (SIDA), was held in Leon, Nicaragua, and a summary of available data was 
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compiled in a report by Cuadra et al (28). The authors concluded that there are areas in El Salvador 
and Nicaragua with a high prevalence of CKD and that possible risk factors were agricultural work, 
sugarcane work, pesticide exposure, and alcohol consumption. Data and studies from other Central 
American countries (Costa Rica, Honduras, Belize, Panama, and Guatemala) were found to be 
lacking.  
Nicaragua and El Salvador are the most affected countries in the region. Several cross-sectional 
studies and other prevalence studies have been conducted in these two countries, and some studies 
have been performed in other Central American countries, including Guatemala and Costa Rica. 
Summaries of the most important studies are presented in the sections below. 
1.3.2.1 El Salvador 
The first cross-sectional study was published in the Spanish journal Nefrologia in 2005 and was a 
study of 353 men in El Salvador, of whom 291 were living near the coast and 62 were living in inland. 
The prevalence of CKD was found to be high, 12.7%, among the men living along the coast. Of the 
affected individuals, 62% did not have hypertension, diabetes, or any other clear cause for their CKD 
(29).  
In 2011, the first prevalence study of a larger population was published. Seven hundred seventy-five 
adult individuals from the Baja Lempa region, located along the Pacific coast of El Salvador, were 
included, and 17% of the men and 4% of the women had reduced kidney function with eGFR <60 
ml/min/1.73m². Risk factors associated with CKD were male sex, age, hypertension, and family 
members with CKD (22).  
One year later, Peraza et al (21) published a prevalence study of 664 inhabitants aged 20-60 years 
living in five different villages, two of which were at low altitude near the coastline with mainly 
sugarcane cultivation and three of which were located 500 meters above sea level with mainly 
sugarcane cultivation, coffee cultivation, and urban/service orientation, respectively. They reported 
that 18% of the men living in the two coastal sugarcane communities had CKD (eGFR <60 
ml/min/1.73m²) compared to only 1.8% of the men in the high-altitude sugarcane village and 0% of 
men in the coffee and service-oriented villages. A significant association was found between CKD 
and more than 10 years of costal sugarcane work. 
A cross-sectional study of 11 communities in three different regions in El Salvador was reported by 
Orantes et al in 2014 (23). The study was conducted between 2009-2011 and from a door-to-door 
census they identified 5018 individuals ≥18 years of age of which 2388 individuals were included in 
the study (23). The prevalence of CKD (CKD defined as eGFR <60 ml/min/1.73m²) was 17% among 
men and 7% among women, and of these CKD cases 52% did not have diabetes mellitus, 
hypertension, or proteinuria. Age ≥60 years was associated with CKD in all three regions, and 
agricultural work was associated with CKD in two regions.  
Another descriptive cross-sectional study of 223 individuals living in two Salvadoran rural 
agricultural communities found that the prevalence of CKD stage 3-5 (eGFR <60 ml/min/1.73m²) was 
16%, but contrary to what has been reported from other studies, CKD was more common in women 
(21% compared to 11% among men). The majority of participants worked in agriculture in the two 
communities, including 96% and 97% of the men and 57% and 52% of the women. Seventy-seven 
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percent of all participants reported agrochemical exposure, and 69% reported use of nonsteroidal anti-
inflammatory drugs (NSAIDs) (30).  
A recent 10-year community registry study reporting the annual incidence of ESRD and CKD 
mortality was conducted in the Baja Lempa region, one of the MeN “hot-spot” regions (31). The 
annual incidence rate of ESRD was 1410 cases per million people. Eighty-nine percent of the patients 
who were diagnosed with ESRD were male, 76% were farmers and 66% did not report hypertension 
or diabetes mellitus. The annual mortality rate due to CKD was found to be high, 128 per 100 000 
inhabitants, compared to other countries in Latin America (32), and the average age at the time of 
death due to CKD was only 56 years. Furthermore, the study reported that only 35% of the patients 
with ESRD received RRT, highlighting the lack of health care resources in El Salvador.  
Of the patients that do receive RRT in El Salvador, the treatment is often of deficient quality. A 
nationwide survey reported that only 41% of the patients treated with peritoneal dialysis treatment 
received optimal treatment (i.e. continuous ambulatory peritoneal dialysis or ambulatory peritoneal 
dialysis with a soft catheter) and that less than 5% of the patients on hemodialysis received optimal 
treatments, (i.e. ≥ 3 hemodialysis treatments per week) (33). 
1.3.2.2 Nicaragua 
In 2010, Torres et al published the first large-scale cross-sectional study from Central America in an 
international scientific journal (20). They included 1096 participants between 20 and 60 years of age 
from five villages with different economic profiles in one of the most affected regions, Northwestern 
Nicaragua. The prevalence of CKD (defined as eGFR <60 ml/min/1.73m²) was highest in the 
mining/subsistence farming village with 19% of men and 5% of women affected (the definition of 
subsistence farming is growing crops for personal use). The prevalence was 17% in men and 4% in 
women in the banana/sugarcane village and 10% in men and 2% in women in the fishing village. 
Interestingly, CKD prevalence was low in both the service-oriented village (0% in both men and 
women) and the coffee-cultivation village (7% in men and 0% in women). The coffee-cultivation 
village was located at a higher altitude, with a colder climate, compared to the other agricultural 
villages in the study. Decreased renal function in this study was common in agricultural workers 
working in low-altitude villages, but was also common in craftsmen, constructions workers, and 
miners. 
Sanoff et al studied 997 individuals in the region of Leon and Chinandega, by measuring serum 
creatinine and blood pressure and by distributing questionnaires. Twelve percent of the participants 
had reduced kidney function with eGFR <60 ml/min/1.73m². In a logistic regression model 
agricultural work was significantly associated with higher odds of reduced renal function with an odds 
ratio (OR) of 2.48 (95% CI 1.59-3.89). Other significant associations with decreased renal function 
were consumption of local alcohol (“lija”) and high water intake (≥5L/day vs. 1L/day) (34).  
A high burden of disease among the younger part of the population was reported in a study by 
O’Donnell et al. That study showed a high prevalence of reduced eGFR (<60 ml/min/1.73m²) among 
18-29 year old individuals and among 30-41 year old individuals, 2.6% and 7.4% respectively and this 
prevalence was significantly higher than data from the US population (0.2% and 0.8% respectively) 
(35). 
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The prevalence of CKD in a high-altitude coffee-cultivating village in Nicaragua (1000 meters above 
sea level) was studied in a cross-sectional study of inhabitants aged 20-60 years. Two hundred ninety-
three participants were interviewed, and urine and blood samples from 267 of those inhabitants were 
collected. No increased prevalence of CKD (eGFR <60 ml/min/1.73m²) was found (0% among men 
and 1.4% among women). Interestingly, 92% of the participants worked in agriculture and 93% 
reported working with preparing or applying pesticides (36). 
Another study highlighting the high risk for sugarcane workers to develop CKD was reported in 2014 
by Raines et al (19). Four hundred twenty-four individuals between 15 and 69 years of age living in a 
community near the town of Chichigalpa in North Western Nicaragua, a MeN hot spot area, were 
studied. The prevalence of eGFR <60 ml/min/1.73m² was as high as 42% among men and 10% 
among females. Hypertension was uncommon, and macroalbuminuria (i.e. >300 mg/dl) was present 
only in less than 10% of the participants with reduced kidney function. A majority of the men were 
involved in sugarcane cultivation. Risk factors for lowered eGFR were total days cutting sugarcane, 
pesticide inhalation, and chewing sugarcane.  
Uric acid levels were measured in a cross-sectional study of 266 individuals in 24 CKD-affected 
families in a MeN hot-spot in Nicaragua (37). Participants with CKD were reported to have 1.2 mg/dl 
higher serum levels of uric acid compared to CKD patients in a large US cohort (NHANES) when 
adjusting for age and eGFR. The authors proposed that the higher uric acid levels in MeN patients 
could contribute to MeN pathogenesis. However, when comparing participants aged ≤ 65 years of age 
with CKD or when comparing Hispanic participants in the Nicaraguan cohort to the US cohort there 
was no statistical significant difference in uric acid levels, indicating that the uric acid levels may 
depend on diet or other factors.   
The only cross-sectional study involving adolescent subjects was reported in 2015 by Ramirez-Rubio 
(38). They studied 12-18 year-old pupils, with no prior work history, in four different schools from 
areas with different MeN prevalence in Nicaragua. Questionnaires and urine biomarkers were 
collected. “Chistata” (see 1.3.4.2) was a common self-reported symptom. Proteinuria and glycosuria 
were rare (3.5% and 1% respectively) and were similar in all groups, but the tubular injury biomarkers 
neutrophil gelatinase-associated lipocalin (NGAL) and N-acetyl-beta-D-glucosaminidase (NAG) were 
higher among adolescents from the area with the highest MeN prevalence, indicating that renal injury 
might occur before occupational exposure begins.  
González-Quiroz and colleagues have started a longitudinal study of 360 young adults (aged 18-30 
years) without any known prior diseases living in nine agricultural communities (mainly sugarcane 
cultivation) in North Western Nicaragua. Baseline findings from this study show that among 
presumed healthy men a high percentage, 11%, had an eGFR below 90 ml/min/1.73m², whereas in 
women the prevalence was 1% (39). Future reports from this longitudinal study will add important 
information on young people living in a MeN hot spot area.    
1.3.2.3 Costa Rica 
The geographical distribution of CKD mortality in different regions of Costa Rica between 1970 and 
2012 was reported by Wesseling et al (2015). In the coastal north-west region Guanacaste, where 
sugarcane cultivation is common, and from where MeN cases have been reported, the standardized 
CKD mortality rate for men ≥20 years of age increased from 4.4 per 100 000 in the 1970s to 38.5 per 
100 000 in 2012 (compared to an increase from 3.6 to 8.4 per 100 000 in the rest of Costa Rica). For 
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women in Guanacaste, the increase was also apparent, but less pronounced. The report supports that a 
high CKD mortality rate in Guanacaste, the hottest region of Costa Rica, has been evident since the 
1970s and that rates have been increasing ever since.        
1.3.2.4 Guatemala 
In 2015, Laux et al published a study describing enrolment rates of RRT in Guatemala. They reported 
that dialysis enrolment was higher in south-west Guatemala close to the Pacific coast, where the 
temperature is higher and sugarcane cultivation is more common, indicating that the MeN endemic is 
probably also affecting this part of Central America (40). A cross-sectional study by the same team 
was published one year later, including 242 patients on hemodialysis in southwestern Guatemala, and 
concluded that 19% of the patients lacked traditional risk factors for CKD, a relatively low percentage 
compared to what has been reported from El Salvador and Nicaragua. More studies are warranted to 
determine the extent of MeN in the Guatemalan population, but it is probably not as prevalent as it is 
in Nicaragua and El Salvador.   
1.3.2.5 Summary    
From these studies, one can conclude that MeN is found in several parts of Central America, and in 
certain areas the prevalence is very high. Men working in manual labor, especially sugarcane workers, 
in certain regions located at low altitudes close to the Pacific coastline are mainly affected, but women 
in these areas also seem to be at some increased risk to develop CKD. One study of adolescents 
indicated that renal damage might occur already before occupational exposure, but more studies are 
needed to establish if there is an association with a development of CKD. In some areas, especially in 
higher altitude environments, inhabitants are not affected by the disease even though they are engaged 
in similar agricultural plantation work. MeN progresses to ESRD in many cases, and the health care 
resources in the afflicted areas are not sufficient to treat all affected individuals.   
1.3.3 Longitudinal and cross-shift studies 
Because sugarcane workers have a high prevalence of MeN and because years of sugarcane work has 
been reported as a risk factor, a few longitudinal studies and cross-shift studies during workdays have 
been conducted to assess if there are any biochemical signs of kidney injury related to sugarcane 
work. However, these types of studies are generally very difficult to perform in Central America, in 
part because close cooperation needs to be established with the sugarcane companies and because 
participants might move or change employers during a harvest season. The present security situation 
in El Salvador, with high rates of crime and violence is also an important factor.     
Laws et al (2015 and 2016) (41, 42) investigated 284 sugarcane workers in Nicaragua before and at 
the end of the six-month long harvest period. Urinary injury markers and serum creatinine were 
measured, and different task assignments were identified, including cane cutters, seed cutters, seeders, 
irrigators, agrochemical applicators, drivers and factory workers. All tasks except for driving and 
factory work were considered to involve medium to high risk for heat stress exposure. A mean eGFR 
change of -6.9 ml/min/1.73m² was found among field workers compared to non-field workers (drivers 
and factory workers). Urinary NGAL and IL-18 levels were also elevated compared to non-field 
workers. The eGFR decrease was significant in seed cutters and irrigators, but it was not significantly 
decreased in agrochemical applicators compared to factory workers. Albuminuria was found in less 
than 5% of the workers. This study provide some evidence that the decrease in eGFR might be 
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associated with field work and heat exposure. However a possible confounding factor might be that 
eGFR was calculated from serum creatinine levels, which might be influenced by increased muscle 
mass or changes in diet during the harvest period.  
In 2016, Wesseling et al published a study of 29 young sugarcane cutters (age 17-38 years) in 
Nicaragua, measuring renal biomarkers in blood and urine before and after the workday on the first 
day of the harvest season, on the sixth day, and after 9 weeks of harvest. At 9 weeks, the pre-shift 
mean levels of creatinine had increased 20% corresponding to a mean eGFR decreased of 10 
ml/min/1.73m². Blood urea nitrogen (BUN) and urinary NGAL also increased significantly during the 
9-week period, while serum phosphate and potassium decreased. Significant increases in serum 
creatinine levels after the workday were reported from all three sampling days (43) indicating renal 
damage and/or muscle damage.  
Another cross-shift study of sugarcane workers, this time in El Salvador, was published in 2015 by 
Garcia-Trabanino et al and included 189 workers aged 18-49 years from three different plantations. 
Urine and blood samples were collected before and after a work day (mean 4 hours worktime with a 
mean temperature of 34-42° C). Fourteen percent of the participants had an eGFR below 60 
ml/min/1.73m² pre-shift. During the work day, there was a statistically significant increase in serum 
creatinine, BUN, and uric acid of about 10% after a work shift as well as increases in urine density, 
urine creatinine and osmolality. Serum chloride and potassium levels decreased during the work day. 
The authors concluded that these results were consistent with repeated dehydration due to heavy 
physical labor in a hot and humid environment (44).  
1.3.4 Clinical presentation 
Most patients with MeN have no, few, or unspecific symptoms, and they receive the diagnosis based 
on decreased eGFR based on serum creatinine measurement. According to local physicians, most 
patients are found in screening programs in affected communities, in screening of sugarcane workers 
before the harvest season, or when the patients develop symptoms of uremia and seek medical care at 
the hospital. When we were starting our studies in 2012, no reports on kidney biopsy findings or renal 
morphology had been published. 
1.3.4.1 Blood pressure 
Blood pressure is usually normal in patients with MeN and cross-sectional studies in Nicaragua and El 
Salvador have shown that the prevalence of hypertension is between 18-37% among those participants 
who have elevated serum creatinine levels (20, 21, 45). Blood pressure levels in patients with MeN 
seem, from these reports, to be lower than expected in the general CKD population (46).   
1.3.4.2 Chistata 
Sugarcane workers in Central America often complain about what is locally called “chistata”, a group 
of symptoms including dysuria and lower back pain. In a study by Ramirez-Rubio et al (47) from 
Nicaragua, 19 physicians and pharmacists working in an area with high prevalence of MeN were 
interviewed, and they reported that “chistata” symptoms are considered by some professionals to be 
urinary tract infections and are sometimes treated with antibiotics without a urine culture 
confirmation. Many of the interviewees also stated that they thought dehydration could be a possible 
cause of the “chistata” symptoms. A recently published study of sugarcane workers, construction 
workers and farmers in Nicaragua reported that “chistata” symptoms were common in all three groups 
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at between 42% and 48% (48). Dysuria has also been reported as a frequent symptom among 
adolescents in Nicaragua; however, urine dipsticks in the same subjects were mostly normal, i.e. 
neither leucocyte esterase nor nitrite positivity was observed (38). In a study performed by the Boston 
University School of Public Health (49), urine cultures were collected from 103 sugarcane workers in 
western Nicaragua (including 29 workers with dysuria symptoms and 30 workers with positive 
leukocyte esterase on urine dip stick). All were negative, indicating that “chistata” symptoms probably 
are not correlated to urinary tract infections, at least not common urinary pathogens. Currently, there is 
no explanation for what is causing these unspecific urinary tract symptoms.   
1.3.4.3 Urine  
Proteinuria is often absent or of non-nephrotic range in MeN. In a cross-sectional study in Nicaragua 
by Torres et al in 2010, 62% of the men and 67% of the women with CKD (eGFR <60 
ml/min/1.73m²) displayed no proteinuria, and only 12% and 6% respectively showed proteinuria 
greater than 300 mg/dl (20). In another cross-sectional study from El Salvador, only 14% of the men 
and 26% of the women with CKD (eGFR <60 ml/min/1.73m²) were found to have proteinuria and all 
participants with proteinuria had levels below 300 mg/dl, i.e. of non-nephrotic range (21). In 
Nicaragua, a slightly higher prevalence of proteinuria has been reported from a cross-sectional study 
of 424 individuals in a MeN hot spot area. Among those with CKD (eGFR <60 ml/min/1.73m²) 44% 
had proteinuria ≥30 mg/dl but only 9% had proteinuria ≥300 mg/dl (19). 
 
1.4 CKDu IN SRI LANKA 
 
 
 
 
 
 
 
 
1.4.1 Overview 
Over the past two decades, a high prevalence of CKDu has been reported from rural areas in Sri 
Lanka, especially among rice paddy farmers in the North Central Province of Sri Lanka, where the 
climate is hot and dry (50, 51) (Figure 6). Men seem to be affected more often than women (52, 53). 
Many different possible etiologies such as pesticides/agrochemicals, heavy metals, fluoride in the 
drinking water and water hardness have been discussed (50, 54, 55), but as yet no convincing 
evidence has been presented. Many clinical and biochemical findings seem to be similar to the MeN 
epidemic in Central America, i.e. patients with mild or moderate kidney failure are often 
Figure 6: Map of Sri Lanka. North 
Central Province is marked in red.                                                                
Source, Map Data ©2017 Google.  
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asymptomatic or complain about back pain or dysuria, urine findings are scarce, proteinuria is usually 
<1g/day, and ultrasound shows reduced kidney size (56). 
One of the first published reports addressing the extent of the CKDu endemic was a retrospective 
study evaluating clinical records from 492 CKD cases at two nephrology units in which they found 
that the cause of CKD was unknown, i.e. it was not correlated to diabetes mellitus, hypertension or 
other known cause, in 54% and 82% of the cases respectively. The patients with CKDu had few 
symptoms and urine sediment was without active deposits (56).  
In general, comprehensive epidemiological data about the CKDu endemic and detailed clinical 
descriptions of patients with CKDu in Sri Lanka are lacking. Screening for most studies has been 
based on dip-stick proteinuria, and only participants with proteinuria have been further evaluated with 
serum creatinine, thus missing patients who only have elevated creatinine levels. Many studies 
regarding CKDu in Sri Lanka have instead focused on identifying risk factors and possible etiologies.   
1.4.2 Prevalence studies 
In a publication by Chandrajith et al, preliminary findings from prevalence studies of inhabitants in six 
different regions were presented. The populations were screened for proteinuria, and the prevalence of 
CKD was found to range between 2-5% in the different regions. This prevalence is not very high; 
however, in endemic areas in the North Central Province a high percentage (84%) of the patients with 
CKD had CKDu compared to a much lower CKDu prevalence in non-endemic regions (54). 
A more comprehensive study by Athuraliya et al was published in 2011 and studied 6153 inhabitants 
in three different regions, the North Central, the Central, and the Southern region. Participants with 
albuminuria on two out of three occasions were included and further evaluated with serum creatinine, 
urine sediment, blood pressure, kidney length measurement, etc. The CKD prevalence (defined as 
proteinuria ≥ 1+ on urine dipstick) in the three regions was 5%, 10%, and 2%, respectively, but in the 
North Central region 87% of the CKD cases were of unknown etiology, while diabetes and 
hypertension were the main risk factors of CKD in the other two regions. In the North Central 
province, men were more often affected than women, and in logistic regression models, being a 
farmer and being >60 years of age were found to be predictors of CKD (53).  
Another cross-sectional study of 4957 participants included by screening for dip-stick albuminuria in 
endemic areas, showed a CKDu prevalence (defined as CKD stage 1-5 without known cause, no 
diabetes mellitus and blood pressure <160/100) of 17% in women and 13% in men. Among the 
women, >85% were in CKD stage 1 and 2, while a higher percentage of the men were in more severe 
CKD stages (55% in stage 1 and 2, and 45% in stage ≥3). CKD prevalence increased with older age 
and a family history of CKD was found in 20% of the CKDu cases (57).  
Jayasekara et al (2015) screened 7604 individuals >5 years of age in the North Central Province for 
dip-stick proteinuria, and individuals with two consecutive positive samples were referred to a renal 
clinic for CKDu investigation. The authors reported that 6.3% of the screened population had CKDu, 
but the criteria for CKDu diagnosis were not presented, making an evaluation of the results difficult. 
They also collected information regarding the water source and reported CKDu to be more prevalent 
in individuals drinking water from shallow wells compared to natural springs. In the same article, the 
authors described a cohort of 3996 patients with newly diagnosed CKD from CKDu endemic areas 
and reported that the male to female ratio was 2.4:1 and that the CKDu prevalence was 70% (58).   
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In summary, the reported prevalence of CKD in these studies is not very high, but a high percentage 
of patients with CKD in the North Central Province were reported to have CKDu. However, the 
prevalence of CKD might be higher than reported because the studies only included participants with 
proteinuria and thus inhabitants with reduced kidney function without albuminuria were not included. 
Men and farmers seem to be more often affected by CKDu and the disease becomes more prevalent 
with older age.  
1.4.3 Case-control studies 
A few case-control studies have been conducted in Sri Lanka to try to establish possible risk factors 
and causes behind the endemic.  
In one on the first case-control studies, interviewer-administered questionnaires from 183 patients 
with CKDu in Anuradhapura, in the endemic North Central Province, were collected and compared to 
200 controls. Risk factors for CKDu were farming, pesticide use, drinking well water, Ayurvedic 
medicine use, family history of CKD, and snake bites. However, in logistic regression analysis, the 
only significant predictors were family history, snake bites, and Ayurvedic treatment (59).   
Nanayakkara et al (2014) studied 311 CKD cases and 286 controls in two CKDu endemic areas in the 
North Central Province. Being a farmer, having a family history of CKD, snake bites, and tobacco 
chewing were found to be associated with CKDu in a multiple logistic analysis. Another interesting 
thing in this study is that 43% of the recruited “healthy controls” had to be excluded due to 
hypertension, elevated HbA1c, proteinuria, or elevated serum creatinine, indicating that non-
communicable diseases are frequent in Sri Lanka (60). 
1.4.4 Clinical presentation 
The patients usually have a rather normal clinical profile, except for increased serum creatinine, 
although some vague symptoms of backache and dysuria have been reported (56). BMI and blood 
pressure are in most cases normal (53, 60), but one study has reported that a high percentage of CKDu 
patients have low BMI (52). In population studies, mean serum sodium, potassium, calcium, 
phosphate, and uric acid levels have been normal (53), but ultrasound of the kidneys has shown 
reduced kidney length (53, 56).  
In urine, albuminuria is of non-nephrotic range and is usually < 1g/24 h (53), and biomarkers of 
tubular injury such as α-1-microglobulin (A1M), NAG, NGAL and Kidney Injury Molecule-1 (KIM-
1) are often elevated (60-62). Urine dip-stick and sediment are only reported in a few studies, and the 
majority report normal findings (53), although increased amounts of erythrocytes and leucocytes have 
been reported in a minority of the patients (63). 
1.4.4.1 Kidney morphology 
A number of renal biopsy studies or reports of patients with CKDu in Sri Lanka have been published. 
The morphology is in most studies described as a tubulointerstitial disease with interstitial fibrosis, 
tubular atrophy, and varying degree of interstitial inflammation, without immunofluorescence (IFL) 
evidence of immune-complex disease. Chronic glomerular changes such as glomerulosclerosis, 
glomerular hypertrophy, and mild to moderate vascular damages (intimal thickening, arteriolar 
hyalinosis) have also been described. Electron microscopy findings have not been reported.  
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Biochemical and clinical data from biopsied patients are largely lacking. Summaries of the main 
findings in each biopsy study are presented in the text below, and in all of the studies the majority of 
the patients had proteinuria or proteinuria was one of the inclusion criteria. 
Athuraliya et al (2011) presented a prevalence study of CKD in three rural communities. In one 
community, Medawachchiya in the northern dry region, 87% of CKD cases did not have a clear cause 
or risk factor. Of these participants 26 underwent renal biopsy with morphological findings indicating 
tubulointerstitial disease with varying degrees of interstitial fibrosis. IFL was negative. However, no 
semi-quantification or details were provided regarding the morphology in this report (53).  
A more detailed description of the morphology was provided by Nanayakkara et al in 2012 (64). They 
evaluated 64 renal biopsies from CKDu patients who underwent renal biopsy at Anuradhapura 
hospital, one of the CKDu hot spots in Sri Lanka. Patients with diabetes mellitus, malignant 
hypertension, and other known etiologies were excluded. The mean age of the patients was 45 years, 
they were in CKD stage 1-4 and 55% (!) had hypertension at the time of the biopsy. The authors 
described the main morphological findings to be interstitial fibrosis and tubular atrophy, but they also 
reported a high percentage of global glomerular sclerosis (37%), glomerular enlargement (37%), and 
collapsing glomeruli (18%) as well as mild to moderate vascular changes. Unfortunately no clinical 
and biochemical data such as albuminuria or other serum and urine characteristics were reported in the 
article.  
In 2015, Wijetunge et al published results from a retrospective study of 251 renal biopsies (65) 
collected at the Teaching Hospital Kandy and General Hospital Anuradhapura. Inclusion criteria were 
residence in a CKDu endemic area for ≥ 5 years, the presence of an interstitial renal disease not 
secondary to a glomerular or systemic disease, the absence of primary or secondary glomerular 
disease, and negative IFL. Patients with systemic disease known to cause kidney injury were 
excluded. The mean age of the patients was 37 years and 77% were men. Proteinuria (dip-stick ≥ 1+) 
was present in 83% of the cases. The authors presented the morphological findings for CKD stage 1-4. 
Stage 1 disease is described as mild to moderate interstitial fibrosis, stage 2 as moderate interstitial 
fibrosis with or without interstitial inflammation, stage 3 as moderate to severe interstitial fibrosis, 
moderate interstitial inflammation, tubular atrophy, and mild glomerulosclerosis, and stage 4 as, 
severe interstitial fibrosis, inflammation, tubular atrophy, and glomerulosclerosis. A weakness of the 
study is that the inclusion criteria “presence of an interstitial renal disease not secondary to a 
glomerular or systemic disease” probably excluded biopsies with glomerular damage, making it 
difficult to interpret the results of this study.  
An interesting study by Badurdeen et al described renal biopsy findings and clinical data from 59 
patients from CKDu endemic regions presenting with acute symptoms (backache, dysuria, fatigue, 
joint pain, and/or dyspepsia) and elevated creatinine levels (66). The majority of the included patients 
were male farmers and the mean age was 44 years. C-reactive protein (CRP) was elevated in 49% of 
the patients, and 49% had leukocyturia. Renal biopsies showed interstitial lymphocyte infiltration in 
97% of the biopsies and tubulitis in 81%. Glomerulosclerosis, interstitial fibrosis, and tubular atrophy 
were also common features. The authors concluded the overall picture to be compatible with acute 
tubulointerstitial nephritis and proposed that this acute episode is followed by scarring and a 
pathological process leading to CKDu. A weakness of this study is that vascular renal structures are 
not described and no morphological pictures are available for the reader to see how the authors have 
evaluated the biopsies.  
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1.5 OTHER ENDEMIC NEPHROPATHIES 
1.5.1 Aristolochic acid nephropathy / Balkan endemic nephropathy 
Balkan endemic nephropathy is one of the most infamous endemic nephropathies. A high incidence of 
CKD was described in certain villages on the Balkan Peninsula already in the 1950s, and later a close 
association with upper urinary tract carcinomas became evident (67). The endemic was named Balkan 
Endemic Nephropathy (BEN). The renal morphology displayed tubulointerstitial atrophy, 
tubulointerstitial fibrosis and often multifocal urothelial atypia. Typically, glomeruli were spared, 
although secondary glomerular and vascular lesions could be present (68). For many years the 
etiology behind the disease was unknown.  
In 1993, a report from Belgium was published describing nine women who developed interstitial 
fibrosis and renal failure after intake of slimming herbs containing aristolochic acid (69). The renal 
morphology was found to be similar to BEN cases, and the Belgian patients also developed urothelial 
carcinoma (68). Aristolochic acid had already in the 1970s been proposed as a possible etiology in 
BEN, because an aristolochic acid-containing plant was found growing in wheat fields in endemic 
areas and could contaminate the processed flour. However, this hypothesis was forgotten for many 
years until the report from Belgium appeared. 
Further studies have identified aristolactam-DNA adducts and specific TP53 mutations in renal tissue 
of patients with BEN (70) and in patients with urothelial malignancies associated with the use of 
herbal medicines containing aristolochic acid in Taiwan (71). Thus, the diseases are regarded to have 
the same etiology and have thus been given the name aristolochic acid nephropathy. 
1.5.2 Heavy metals 
Many heavy metals are toxic to humans, and some heavy metals are also known to cause kidney 
damage. Lead, cadmium, and mercury are the most well-described heavy metals associated with 
kidney damage, and in most cases the exposure to the metal has been occupational.     
Lead poisoning resulting in kidney damage is rare and requires high exposure to lead that would cause 
symptoms of lead poisoning in other organs. A typical morphological finding is intranuclear lead 
inclusions in tubular epithelial cells (72), but usually a diagnosis of lead nephropathy is based on a 
history of lead exposure in combination with reduced kidney function and renal biopsy morphology 
with non-specific findings, e.g. chronic tubulointerstitial damage and nephrosclerosis (73). A review 
of cross-sectional studies of occupational lead-exposed individuals by Evans and Elinder (74) 
concluded that lead nephropathy is a rather infrequent finding and that the presumption that non-toxic 
lead levels can cause CKD does not yet have supportive evidence.  
Cadmium can cause kidney damage characterized by tubular proteinuria, which usually is irreversible 
(75). Kidney function may deteriorate, but severe CKD is uncommon. Cadmium exposure is in most 
cases due to smoking, eating contaminated foods, or occupational exposure (e.g. working in the 
industrial battery industry) (76). Renal biopsy descriptions are scarce, but a case description of the 
morphology after cadmium poisoning shows severe tubular atrophy, interstitial fibrosis, subcapsular 
inflammation, and chronic glomerular damage (77).    
Mercury-induced kidney damage typically causes nephrotic syndrome and tubular injury where the 
proteinuria usually vanishes when exposure ends. Typically the morphological findings are 
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membranous nephropathy, but in some cases minimal change lesions have been reported (78). 
Exposure to mercury is mainly through diet (fish) and dental amalgam fillings or through occupational 
exposure, e.g. the chloralkali industry or dentistry. The effects of amalgam fillings on health has been 
debated, but there is no evidence that mercury from amalgam fillings is nephrotoxic or can cause other 
significant adverse health effects (73, 79).     
1.5.3 CKDu in India / Uddanam nephropathy 
A high incidence of CKDu has also been reported from certain regions in India, especially in the rural 
areas of the Andhra Pradesh region (80). This endemic disease has been named Uddanam 
nephropathy. Published scientific data is scarce, but local media has reported on the steadily 
increasing need of dialysis treatment (81). An unpublished cross-sectional study presented in an 
abstract in 2009 (82) studied 443 individuals in a village in the Srikakulam district in Andhra Pradesh 
region and reported that 55% of the inhabitants had CKD with eGFR <60 ml/min/1.73m². The study 
also reported that the high prevalence was not associated with traditional risk factors for CKD like 
diabetes and hypertension and that only 15% of the affected individuals had proteinuria. Renal 
biopsies from patients showed normal glomerular structures, lymphocytic peritubulitis, tubular 
atrophy, interstitial fibrosis, and normal vessels. 
The cause of CKDu in India or Uddanam nephropathy is not known, but various etiologies have been 
suggested such as environmental toxins/pesticides, chemicals in the water and heat exposure (83, 84).   
The CKDu endemic in India seems to have some similarities with CKDu endemics in other countries 
with warm climates, such as MeN in Central America and CKDu in Sri Lanka. All of these CKDu 
epidemics have in common that they mainly affect poor rural farming communities, and clinically the 
patients do not have diabetes or hypertension and a majority of patients does not have proteinuria (15, 
85). However, the CKDu endemic in India is, as of yet, insufficiently described and further studies are 
needed to determine the prevalence and clinical characteristics of the disease before a comparison can 
be made with CKDu endemics in other countries.   
 
2 AIM OF THE STUDIES 
The aim of this thesis was to describe and characterize case series of patients with MeN in Central 
America and CKDu in Sri Lanka with a focus on renal morphology and biochemical characteristics to 
enhance our understanding of the endemics, including possible pathophysiological processes and 
etiologies. With this detailed description of case series the aim was also to be able to compare the 
endemics and elucidate if the diseases are similar diagnostic entities.  
The specific objectives for the studies were as follows. 
Study I 
 To describe the renal morphology in Mesoamerican nephropathy, which has not previously 
been described. 
 To analyze urine and blood samples and clinically relevant data, including work history and 
medical history in order to provide a detailed description of affected individuals.  
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Study II 
 To describe the renal morphology and biochemical characteristics of Mesoamerican 
nephropathy in another Central American country using a similar study design as in Study I. 
 To study heavy metals in the urine of affected individuals in order to evaluate any toxic 
exposure to these compounds.  
 To collect a detailed assessment of the use of analgesic medicines. 
 To study the natural history of Mesoamerican nephropathy by collecting follow-up blood and 
urine samples from the participants in Studies I and II.  
Study III 
 To describe the renal morphology and biochemical characteristics in patients with CKDu in 
Sri Lanka using a similar study design as in Studies I and II.  
 To compare the results with Studies I and II in order to elucidate if Mesoamerican 
nephropathy in Central America and CKDu in Sri Lanka are related diseases.  
 
3   MATERIAL AND METHODS 
All studies were conducted in May or June, i.e. outside of harvest season. Participants in all studies 
were patients who had a CKD diagnosis from a nephrology unit or an occupational health clinic in 
each country. All participants were recruited by local physicians/nephrologists.  
3.1 STUDY SUBJECTS 
3.1.1 Study I 
Male patients with CKD of unknown cause living and/or working in affected areas in El Salvador 
were recruited by Dr. Ricardo Leiva and co-workers at the Department of Renal Medicine, Hospital 
Nacional Rosales, in San Salvador, El Salvador.  
Inclusion criteria: 
 CKD of unknown cause, i.e. no clinically known kidney disease diagnosis 
 20-60 years of age  
 Serum creatinine levels of 120-220 µmol/L (1.36-2.49 mg/dl) or eGFR of 30-60 
ml/min/1.73m² 
Exclusion criteria: 
 Diabetes mellitus, defined as fasting blood glucose >7.0 mmol/L (>126 mg/dl)  
 Uncontrolled hypertension, defined as blood pressure >140/90 mm Hg or treatment with more 
than one antihypertensive drug 
 Nephrotic-range proteinuria (24-hour protein excretion >3.5 g).  
3.1.2 Study II 
Male patients with a history of sugarcane work who had been evaluated due to CKD of unknown 
cause at the Research Center of Health, Work and Environment at the National Autonomous 
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University of Nicaragua, León were recruited to the study. Dr. Marvin González-Quiroz was 
responsible for the recruitment. The enrolment was performed during a 12-month period, and all 
patients who fulfilled the inclusion criteria were invited to participate. Changes in inclusion/exclusion 
criteria compared to Study 1 are in bold letters.  
Inclusion criteria: 
 CKD of unknown cause 
 20-65 years of age 
 Serum creatinine levels 100-220 µmol/L (1.13-2.49 mg/dl) or eGFR 30-80 ml/min/1.73m² 
Exclusion criteria: 
 Diabetes mellitus, defined as fasting blood glucose >7.0 mmol/L (>126 mg/dl)  
 Uncontrolled hypertension, defined as blood pressure >140/90 mm Hg or more than one 
antihypertensive drug 
 24-hour protein excretion >3 g 
3.1.3 Study III 
Male patients with chronic kidney disease of unknown cause and who were planned for a renal biopsy 
at Polonnaruwa General Hospital, Sri Lanka, were recruited by Dr. Rajeewa Dassanayake and co-
workers at the hospital’s renal unit. 
Inclusion criteria:  
 CKD of unknown cause 
 20-65 years of age 
 Serum creatinine 100-220 µmol/L or eGFR 30-80 ml/min/1.73m².  
Exclusion criteria:  
 Diabetes mellitus, defined as fasting blood glucose >7.0 mmol/L (>126 mg/dl)  
 Uncontrolled hypertension, defined as >140/90 mmHg or more than one antihypertensive 
drug 
 Proteinuria >1g/24h  
 
3.2 RENAL BIOPSY PROCEDURE 
3.2.1 Overview 
Renal biopsy is a clinically established procedure in the investigation of unknown CKD. In most 
cases, the pathologist’s evaluation of the renal tissue can provide a diagnosis and assess prognosis, and 
the treatment can be altered accordingly. However, complications after renal biopsy may occur. The 
most common complications are hematuria and bleeding. Hematuria occurs in 3-18% of patients, 
bleeding severe enough to cause hypotension occurs in 1-2%, and blood transfusions are required in 
0.9 - 6% (86, 87) of the patients. Major severe bleeding that requires surgery or arterial embolization 
is rare and only occurs in 0.1-0.4% of patients (86). Other minor complications include local pain, 
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drop in hemoglobin level and local soft tissue infection. Late complications, such as the formation of a 
symptomatic arteriovenous fistula are rare. The risk of mortality is 0 - 0.1% (86-88). 
Renal biopsies usually measure 1.2-1.6 × 10-15 mm and are collected from the upper or lower kidney 
pool. If collected correctly, the biopsy should contain mostly kidney cortex (where the glomeruli are 
located) and some medulla. Usually two to three renal biopsies from one kidney are required to make 
a proper morphological evaluation. Risk factors associated with complications are coagulation defects, 
elevated serum creatinine, elevated blood pressure (>140/90 mmHg), and female gender (86, 89). 
Some studies have also reported that young age is a risk factor (89, 90). The needle sizes used to 
collect renal biopsies are normally 14 to 18 Gauge (G). Most studies have not seen any difference in 
complication rates between the different needle sizes (86), although a recent Swedish study reported 
more complications with a smaller needle size of 18 G compared to 16 G (91). Furthermore, the larger 
needle sizes (14 G and 16 G) generally provide better tissue samples (more glomeruli) for 
morphological evaluation and may require fewer biopsies/passes.    
In all three studies, the renal biopsy procedure was conducted according to Swedish and international 
procedures to minimize the risk of complications. All participants had a clinical check-up before the 
biopsy to ensure that blood pressure was normal, that the patients did not have a history of coagulation 
defects, and that the patients had not used any medication affecting blood coagulation (including 
NSAIDs, aspirin, warfarin, heparin, etc.) during the last 2 weeks. Blood tests from participants were 
analyzed with complete blood count, platelet count, prothrombin time (PK)/INR, and APTT before 
the biopsy to ensure that no measurable coagulation defect was present. Ultrasound of the kidneys was 
performed before the biopsy, and if solitary kidney, small hyperechoic kidneys, or other major 
abnormalities were found no biopsy was taken.   
The renal biopsies were collected by experienced local nephrologists using an ultrasound-guided 
percutaneous technique with a spring-loaded biopsy needle (14 G in Study I and 16 G in Study II and 
III) (Figure 7). After the biopsy procedure, the patients remained in a lying position for a minimum of 
6 hours, blood pressure was checked regularly and the urine was controlled for macroscopic 
hematuria. The patients stayed at the hospital for observation for 24 hours after the biopsy. After 
discharge, all patients were followed up with a visit at the nephrology outpatient clinic to receive 
information about the test results including biopsy findings.  
 
 
 
 
 
 
Figure 7: Dr Luis Trujillo and Dr Ricardo Leiva 
preparing for a renal biopsy procedure at Hospital 
Rosales, San Salvador, El Salvador (Study I). The 
patient is awake and lying on his stomach. Ultrasound 
was performed before and during biopsy procedure. 
Photo courtesy of Annika Wernerson.  
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3.2.2 Tissue preparation 
In Study I, the renal biopsies were divided into two parts immediately after the biopsy procedure. One 
part was placed in phosphate-buffered 4% formaldehyde and stored at ambient temperature and the 
other part was snap frozen in liquid nitrogen and then stored in a freezer at -18°C. 
In Study II, the renal biopsies were divided into three parts immediately after the biopsy procedure. 
One part was placed in phosphate-buffered 4% formaldehyde at ambient room temperature, and one 
part was snap frozen in liquid nitrogen and stored at -20°C. The third part for transmission electron 
microscopy (TEM) was put in a 0.1 M phosphate buffer with 2.5% glutaraldehyde and 0.5% 
paraformaldehyde.  
In Study III, the renal biopsies were divided into three parts immediately after the biopsy procedure. 
One part was placed in phosphate-buffered 4% formaldehyde, the second part was placed in Zeus 
fixative solution, and the third part for TEM was placed in 0.1 M phosphate buffer with 2% 
glutaraldehyde and 1% paraformaldehyde. All samples were stored at room temperature.  
Within one week after renal biopsy collection the specimens were transported to Karolinska 
University Hospital in ambient temperature and on dry ice respectively.   
3.2.3 Light microscopy 
Light microscopy is the most important part in evaluating the morphological findings in kidney tissue 
from patients with acute and chronic kidney diseases. The tissue is sectioned and stained according to 
different protocols to facilitate the evaluation of specific structures in the renal tissue. In many cases it 
is possible to find a specific diagnosis after light microscopy evaluation by an experienced pathologist.  
In the studies for this thesis, the formaldehyde-fixed tissues were further embedded in paraffin, 
sectioned into 1-2 µm sections, and stained according to standard protocols with hematoxylin and 
eosin (HE), Ladewig, periodic acid Schiff (PAS), and periodic acid silver methenamine (PASM). 
Polarized light was used to detect any birefringent crystals in the paraffin-embedded tissue (Studies I, 
II, and III) and in frozen sections (Study II, in the nine patients from whom frozen material was 
available). De Galantha´s staining (92) was performed on paraffin-embedded material in Study II to 
detect any urate crystals. 
Light microscopic evaluation of the renal biopsies was performed by Annika Wernerson and Magnus 
Söderberg, two experienced senior consultants at the Department of Clinical Pathology and Cytology, 
Karolinska University Hospital. The initial evaluation was independently performed and blinded to 
study number and biochemical data. After initial evaluation the two pathologists discussed their 
findings to reach consensus (differences between the pathologists’ evaluations were found in about 
every tenth semi-quantifications, but these only changed the results by one step in a four-graded 
scale). The histological findings were semi-quantified according to the scheme in Table 1. Kidney 
specimens with > 10 glomeruli were considered representative, specimens with 7-9 glomeruli as 
marginally representative and specimens with <7 glomeruli as not representative.  
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  Table 1: Morphological parameters evaluated with light microscopy in Studies I, II, and III. 
 Scale Comment 
Glomerular pathology 
Total number of glomeruli Counts  
Globally sclerosed glomeruli Counts  
Segmentally sclerosed glomeruli Counts  
Endocapillary cell proliferation 0-1 0=no, 1=yes 
Matrix increase 0-3  0=no, 1=mild, 2=moderate, 3=severe 
Cell proliferation 0-3  0=no, 1=mild, 2=moderate, 3=severe 
Glomerular size 0-3  0=no, 1=mild, 2=moderate, 3=severe 
Wrinkling of GBM/ 
Thickening of Bowman’s capsule 
0-1  0=no, 1=yes 
Tubulointerstitial pathology 
Tubular atrophy 0-3  0=no 
 1=mild, 6%-25%  
 2=moderate, 26%-50%  
 3=severe, >50% of the cortical area 
Tubulitis 0-3  0=no, 1=mild, 2=moderate, 3=severe 
Granulocytes in tubuli 0-1  0=no, 1=yes 
Interstitial fibrosis 0-3  0=no 
 1=mild, 6%-25%  
 2=moderate, 26%-50%  
 3=severe, >50% of the cortical area 
Interstitial inflammation 0-3  0=no 
 1=mild, 6%-25%  
 2=moderate, 26%-50%  
 3=severe, >50% of the cortical area 
Vascular pathology  
Intimal thickening 0-3  0=no, 1=mild, 2=moderate, 3=severe 
Smooth muscle hyperplasia 0-3  0=no, 1=mild, 2=moderate, 3=severe 
Arteriolar hyalinosis 0-3  0=no, 1=mild, 2=moderate, 3=severe 
 
3.2.4 Immunofluorescence (IFL) 
IFL is an immunohistochemistry technique used to localize a specific protein in the tissue section. The 
technique uses antibodies that have been conjugated to fluorescent dyes and when the antibody binds 
to an antigen epitope (the protein of interest) in the tissue section, the location and intensity of the 
fluorescence are evaluated using a fluorescence microscope.  
In this study, the specimens for IFL (the snap-frozen tissues from Studies I and II and Zeus solution 
tissues from Study II that had been rinsed and snap frozen) were sectioned into 5 µm cryosections and 
were incubated with FITC-conjugated antibodies against immunoglobulins (IgA, IgG, and IgM), 
complement (C1q, C3), light chains (kappa and lambda), and fibrinogen (antibody manufacturer 
Dako, Glostrup, Denmark). Evaluations were performed by renal pathologist Annika Wernerson using 
a fluorescence microscope (Microphot-FXA, Nikon, Tokyo, Japan). 
3.2.5 Transmission electron microscopy (TEM) 
An electron microscope has a much higher resolution than a light microscope and allows tissue 
samples to be studied on a cellular and subcellular level. Instead of using ordinary light (photons), the 
electron microscope uses a beam of accelerated electrons, and because the electrons have a shorter 
wavelength a more detailed image can be produced. The electron microscopy image is in gray scale 
and reflects the density of different structures in the tissue sample. TEM is the most commonly used 
electron microscopy technique when evaluating tissue samples including renal biopsy samples.   
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TEM is utilized in the routine diagnostic evaluation of renal specimens, in particular to study the 
glomerular compartment of the nephron. The pathology of subcellular structures can be evaluated, e.g. 
the thickness of the glomerular basement membrane (GBM), podocyte foot-process effacement, 
immune complex deposits, etc.    
In the studies for this thesis, the renal biopsy 
specimens for TEM were embedded in epoxy resin 
and cut into 60 nm sections (in Study I, tissues 
stored in formaldehyde were fixed in a 0.1 M 
phosphate buffer with 2.5% glutaraldehyde and 
0.5% paraformaldehyde before being embedded in 
epoxy resin). The sections were then evaluated by 
Kjell Hultenby (head of the Electron Microscopy 
Department) and Annika Wernerson using an 
electron microscope (Tecnai 12, FEI, Eindhoven, 
The Netherlands). GBM thickness was measured in 
five areas in five randomly selected capillaries per 
glomerulus, and the mean thickness was calculated. 
In the same capillaries, podocyte foot-process 
effacement was semi-quantified by calculating the 
numbers of slits per µm GBM (Figure 8). Effacement 
was defined as widespread if ≥80% of the measured 
areas had <1.0 slit/µm GBM, or segmental if 21% to 
79% of evaluated areas had <1.0 slit/µm GBM. 
 
3.3 BLOOD AND URINE SAMPLES 
Within two weeks before the renal biopsy procedure, whole blood analysis was performed on 
participants to measure electrolytes, complete blood cell count (including platelets), and relevant 
coagulation tests (PK/INR, APTT, bleeding time, etc.). In Studies II and III urine samples were 
collected before the biopsy for microscopic examination of urine sediment, urine dip stick, urine 
culture, and 24 hour urine collection (Study II only). In Study I the same samples were collected 2-3 
months after the biopsy. All of these tests were performed by local laboratories (Hospital Nacional 
Rosales laboratory (Study I), the laboratory of the faculty of medicine at National Autonomous 
University of Nicaragua at León (Study II), and General Hospital Polonnaruwa (Study III)). 
New blood samples and urine samples were collected on the morning before the biopsy procedure. All 
participants were fasting, and no intravenous fluid had been given before the sample collection. Blood 
samples were centrifuged, and the supernatant was pipetted into transporting vials. Samples were 
stored in freezers (-18°C, -20°C and -40°C respectively) and then transported within one week on dry 
ice to Karolinska University Hospital where the samples were stored at -70°C pending analysis.  
Table 2 presents the plasma/serum and urine constituents analyzed at Karolinska University Hospital 
Laboratory for the different studies. Urine heavy metals were analyzed in Studies II and III by ALS 
Scandinavia AB Laboratory, Luleå, Sweden. eGFR was calculated using the CKD-EPI equations for 
creatinine, eGFRCr (93); Cystatin C, eGFRCystC (94); and Creatinine + Cystatin C, eGFRCr+CystC (94).  
Figure 8: Transmission electron microscopy image in 
low magnification showing a glomerulus. For 
assessment of GBM thickness and degree of foot-
process effacement five randomly capillaries (squares) 
were studied.  
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Table 2: Plasma/serum and urine constituents analyzed in the study.  
Plasma/Serum  Urine 
 Study I Study II Study III   Study I Study II Study III 
Creatinine x x x  Albumin x x x 
Cystatin C x x x  Creatinine x x x 
Urea nitrogen x x x  Uric Acid x x x 
CRP x x x  Osmolality   x 
Sodium x x x  NAG x x  
Potassium x x x  A1M x x x 
Magnesium x x x  NGAL   x 
Calcium x x x  Sodium x x x 
Uric acid x x x  Potassium x x x 
Albumin x x x  Magnesium   x 
Phosphate x x x  Arsenic  x x 
ALAT* x x x  Cadmium  x x 
ANA screening x x x  Mercury  x x 
ANCA screening x x x  Lead  x x 
Anti-GBM-ab x x x  Uranium   x 
Complement x x x  Vanadium   x 
β2-microglobulin x  x      
Renin x x x      
Aldosterone x x x      
Osmolality  x       
HIV x x x      
Hepatitis B & C x x x      
Leptospira    x      
Hatanvirus   x      
3.3.1 Blood and urine samples follow-up in Study II 
In Study II, follow-up blood and urine samples were collected from patients in Study I (El Salvador) 
and Study II (Nicaragua). From El Salvador, 7 of the 8 original patients were included in the follow-
up and in Nicaragua 18 of the 19 original participants were included, thus 2 of the 27 participants were 
lost to follow up.  
In El Salvador, the samples were collected 19 to 26 months after the renal biopsy. Current 
employment and whether the patient was dead or in dialysis were also reported. Four of the seven 
samples were transported and analyzed at Karolinska University hospital, and three samples were 
analyzed at Hospital Rosales. Creatinine, sodium, and potassium were measured in serum/plasma, and 
albumin, creatinine and NAG were measured in urine. Change in eGFR was calculated.  
In Nicaragua, the samples were collected 13 to 17 months after the renal biopsy. Samples were 
analyzed at Karolinska University Hospital for creatinine, cystatin C, sodium, potassium, and uric acid 
in plasma and for albumin, creatinine, and A1M in urine. Change in eGFR was calculated.  
 
3.4 QUESTIONNAIRES 
In all three studies, patients were interviewed by local physicians/researchers in their native tongue, 
and a questionnaire was filled out by the interviewer. The base of the questionnaire was the same in all 
studies and included questions about employment (current and previous), current use of medications 
(including antihypertensive medicines, NSAIDs and paracetamol/acetaminophen), any use of 
antibiotics in the last 6 months, use of herbal medicines, daily liquid intake, and smoking habits. In 
Study II, the part of the questionnaire regarding analgesic use was more detailed to allow a better 
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assessment of lifetime exposure. In Study III, snake bites, family history of CKD, and pesticide 
exposure were added to the questionnaire.    
 
3.5 STATISTICS 
Since all three studies were relatively small case series, usually only the mean and standard deviation 
and range were reported. However, in Study II, where follow-up samples from both Study I and II 
were combined (n=25), simple linear regression was used to predict change in eGFR per year, based 
on blood and urine results at baseline. In the same study, unpaired t-test was used to compare the 
mean change in eGFRCr per year between groups with different morphology.  
 
3.6 ETHICAL CONSIDERATIONS 
It is standard procedure to collect renal biopsies in the clinical evaluation of chronic kidney disease in 
most middle and high-income countries. Nevertheless, the procedure carries a risk of serious 
complications. One of the most feared complications is post-biopsy bleeding that might require blood 
transfusions, or in severe and rare cases, may require surgery or interventional radiology. In all three 
studies, our first priority was to ensure that the biopsy procedure was conducted safely and according 
to international standards, as described in the section “Renal biopsy procedure”, to minimize the risk 
of complications and to ensure that the biopsies were conducted in facilities where blood transfusions 
could be given and surgeons, if needed, could intervene in case of uncontrolled bleeding. In Studies I 
and II, our local collaborators had experience in performing renal biopsies; however, clinically 
motivated biopsies were rarely carried out due to lack of renal pathologists. In Sri Lanka, on the other 
hand, renal biopsies are more often collected in the clinical evaluation of patients with CKD, and all of 
our included patients in Study III were already planned for a clinically motivated renal biopsy by the 
local physician/nephrologist. Another ethical consideration was to ensure that the participating 
patients received the results from the morphological and biochemical analyses performed in Sweden. 
This was achieved by sending all of the results to the nephrologist in charge in each country who then 
presented the results to the patient and, if needed, altered the treatment accordingly.  
3.6.1 Ethics committee approvals 
Ethics approvals for the studies were received from the Ethics Committee at Hospital Nacional 
Rosales, San Salvador, El Salvador (ACTA N°:03-2012 and ACTA EXP. N°: 11/2016)); the Ethics 
Committee at the National Autonomous University of Nicaragua at León (ACTA No 83, 2013; ACTA 
No 31); the Ethics Review Committee at the Faculty of Medicine and Allied Sciences, Rajarata 
University of Sri Lanka (ERC/2016/06); and from the Ethics Committee in Stockholm, Sweden (Dnr 
2012/441-31/3, 2013/1225-32, 2015/849-32 and 2016/747-32). All participants gave informed 
consent. 
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4 RESULTS 
4.1 STUDY I (EL SALVADOR) 
Eight male agricultural/plantation workers with a mean age of 44 (range 22-57) years were included in 
the study. All participants had normal blood pressure of 100-130/60-80 mmHg and their mean BMI 
was 26 (range 20-35) kg/m².  
4.1.1 Questionnaire 
The number of years working on plantations varied from 8 to 44 (mean 32) years and sugarcane, corn, 
beans and sorghum were the most common crops cultivated at the plantations. Only two patients 
reported any chronic disease (one hypertension and one hyperuricemia), but three patients were on 
antihypertensive medication. NSAID use was frequent, and two patients reported daily use of NSAIDs 
and five reported weekly use. Estimated daily liquid intake was 2.5-5 liters, and water was the main 
liquid consumed.    
4.1.2 Biochemical characteristics 
The mean plasma creatinine was 172 ± 50 µmol/L (1.94 ± 0.57 mg/dl) and the mean eGFRCr was 46 ± 
20 (range 27-74) ml/min/1.73m² in the study group, with two patients in CKD stage 2, four in CKD 
stage 3, and two patients in CKD stage 4. Electrolyte disturbances were common, and low levels of 
plasma potassium and/or sodium were found in six of the eight patients. Low magnesium levels were 
found in four patients, and uric acid was elevated (>7.0 mg/dl) in six of the eight patients. Most other 
biochemical parameters measured in blood showed normal values. Urine dip-stick and sediment 
showed trace, 1+, and 2+ albumin, respectively, in three patients, and in the other patients no 
pathology was found (i.e. no casts, hematuria, glucosuria etc.). Albuminuria was rare, only two 
patients had increased albumin-creatinine ratio (ACR), and both were of non-nephrotic range. Markers 
of tubular damage NAG and/or A1M were elevated in all but one patient.   
4.1.3 Renal morphology 
Renal biopsies of representative quality were collected from all patients. Surprisingly, all eight 
biopsies had a very similar morphology, which did not resemble any other known kidney disease, i.e. 
the results indicate that MeN is a unique diagnostic entity with a specific morphology. The main 
findings are presented in the following sections. 
4.1.3.1 Light microscopy and immunofluorescence 
Extensive glomerulosclerosis, ranging from 29% to 78%, of the included glomeruli was observed in 
the specimens (Figure 9A). In all patients, glomerular hypertrophy and signs of glomerular ischemia 
with wrinkling of the glomerular capillaries and/or thickening of Bowman’s capsule were seen (Figure 
9B, 9D). Segmentally sclerosed glomeruli were observed in two patients.  
The tubulointerstitial compartments showed chronic damage with mild to moderate tubular atrophy, 
interstitial fibrosis, and interstitial inflammation (Figure 9A, 9C), although no specimens displayed 
severe damage. Mild tubulitis was found in one patient, but no neutrophil granulocytes were observed 
in the tubular lumina. In one patient, a few eosinophils were seen in peritubular capillaries. 
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Figure 9: Light microscopy images from Study I. Glomerulosclerosis (stars in A) and glomerular hypertrophy (D) were seen 
in all biopsies. Signs of glomerular ischemia with thickening of Bowman's capsule (white arrow head in B) were common. 
Tubular atrophy (black arrow in A), interstitial inflammation (A and C) and interstitial fibrosis (C) were of mild to moderate 
degree. Arteries were usually normal or had mild changes such as smooth muscle hyperplasia (white arrow in B). Arterioles 
were usually normal, but a few had mild hyalinosis (black arrow in D). A: HE staining from patient 6, bar=200 µm. B: 
PASM staining from patient 2, bar=50 µm. C: Ladewig staining from patient 3, bar=200 µm. D: HE staining from patient 2, 
bar=200 µm. 
Arteries and arterioles in the specimens were normal or had mild pathology (Figure 9B, 9D). In 
arteries, mild intimal thickening was found in only two specimens, but mild smooth muscle 
hyperplasia was found in all but one of the biopsies. Arterioles were mostly normal, although three 
specimens showed mild hyalinosis. IFL on the frozen material did not show any signs of immune-
complex disease, i.e. was negative for immunoglobulins, complement, light chains and fibrinogen. 
4.1.3.2 Electron microscopy (EM) 
In the glomeruli, podocyte foot-process effacement was found in three patients. Vacuoles and fat 
droplets were frequently found in the podocyte cytoplasm (Figure 10). The GBM, endothelial cells, 
and mesangium were normal in most patients. In one patient, small amounts of electron-dense 
deposits were found in the mesangium (subsequent IFL on pronase-treated paraffin-embedded 
material showed small amounts of IgG-deposits in the mesangium (IgA and IgM negative), suggesting 
that the immune complexes could represent a remnant of a previous episode of glomerulonephritis in 
this patient, e.g. postinfectious glomerulonephritis). In the tubuli the evaluation was difficult due to 
fixation artifacts, but no lead inclusions could be seen in the tubular cells.   
A B 
C D 
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Figure 10: Transmission electron microscopy images from patient 1 (A) and patient 7 (B) showing vacuoles (arrow heads in 
A and B) and lipid droplets (arrows in A and B) in the podocyte cytoplasm. N=nucleus. Bars=5 µm. 
 
4.2 STUDY II (NICARAGUA) 
Nineteen male sugarcane workers in Nicaragua with a mean age of 33 (range 24-54) years were 
included in the biopsy study. All participants had normal blood pressure of 105-133/56-88 mmHg and 
their mean BMI was 25 (range 19-37) kg/m². In the follow-up study, 25 patients were included (18 
from the Nicaragua biopsy study and 7 from the El Salvador biopsy study (Study I)).   
4.2.1 Questionnaire – Biopsy study 
The 19 participants had been working with sugarcane cultivation for a mean of 12 (range 2.5-38) 
years. None of the participants were on hypertensive medicines. Among the participants, 32% 
reported previous regular NSAID use (defined as weekly use for ≥ 2 years), and four patients reported 
current use of NSAIDs. Herbal remedy use was common (37%). Mean water intake on work days and 
non-work days was 9 liters and 5.3 liters respectively. Seven subjects reported that they had fainted 
during work (mean 3 times, range 1-6 times). 
4.2.2 Biochemical characteristics – Biopsy study 
The mean plasma creatinine concentration was 146 ± 34 µmol/L (1.66 ± 0.38 mg/dl) and the mean 
eGFRCr was 57 (range 33-96) ml/min/1.73m². Electrolyte disorders were common, and low potassium 
was found in 21% of the participants, low sodium in 47%, and low magnesium in 37%. 
Hyperuricemia was found in 58% of the participants, and 47% had 24 h urine volume > 3 liters, i.e. 
polyuria. Urinary potassium levels indicated renal potassium losses in the patients with hypokalemia. 
Urinary heavy metals were all below toxic levels.  
4.2.3 Renal morphology – Biopsy study 
All 19 participants underwent renal biopsy with 13 biopsy specimens being representative, 3 
marginally representative, and 3 being not representative. The latter were excluded from the group 
analysis. The morphological findings were homogenous and were very similar to the morphological 
findings in Study I. The main findings were as follows. 
A B 
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4.2.3.1 Light microscopy and immunofluorescence  
All specimens showed glomerulosclerosis of varying degree (7-70%) (Figure 11) and glomerular 
hypertrophy. Segmental scleroses were found in two patients, and signs of glomerular ischemia were 
found in all but one patient (Figure 11A). Tubular atrophy and interstitial inflammation were generally 
mild (Figure 11B), and interstitial fibrosis was in most cases mild to moderate. None of the 
participants had severe tubulointerstitial changes. An unspecific finding of a few neutrophil 
granulocytes in the tubuli were observed in two patients and a few interstitial eosinophils were 
observed in two other patients. Arteries were in most cases normal or mildly damaged with mild 
intimal thickening and/or mild to moderate smooth muscle hyperplasia (Figure 11B). Arterial 
hyalinosis was found in 31% of the patients. In all but four patients, material for IFL was available. In 
the available specimens, there were no signs of immune complex disease.   
  
Figure 11: Light microscopy findings from Study II. Glomerulosclerosis (stars in A and B) of varying degree was found in all 
participants. Thickening of Bowman’s capsule (white arrow head in A) was a frequent finding. Tubulointerstitial changes 
were generally mild to moderate, with mostly mild tubular atrophy (white arrow head in B). Arteries were normal (black 
arrow head in B) or mildly changed. A: PASM staining, patient 13, bar=100 µm. B: PAS staining, patient 9, bar=200 µm. 
4.2.3.2 Electron microscopy 
Podocyte foot-process effacement was observed in 56% of the specimens (Figure 12A) and the GBM  
  
Figure 12: Transmission electron microscopy findings in Study II. Podocyte foot-process effacement (black arrow             
heads in A, patient 17) and podocyte cytoplasm inclusion such as vacuoles (arrow heads in B, patient 10) or lipofuscin-like 
bodies were found in the majority of the patients. Endothelial cells were in some cases focally swollen (* in A). C=capillary 
space. N=nucleus. Bars: A=1µm, B=5µm.   
A B 
A B 
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was thickened in a few cases. The endothelium was swollen in 38% of the specimens. Vacuoles and 
lipofuscin-like bodies in the podocyte cytoplasm were a common finding (Figure 12B). Tubular cells 
showed signs of atrophy but no other evident pathology. No immune-complexes were found in any of 
the specimens.  
4.2.4 Follow-up study 
The mean eGFRCr was 45 ± 25 (range 9-76) ml/min/1.73m² in the El Salvador patient group (n=7) and 
52 ± 20 (range 20-87) ml/min/1.73m² in the Nicaragua patient group (n=18) at follow-up, which 
corresponds to a mean change in eGFRCr of -4.4 ± 8.4 (range -27.7-10.2) per year when both studies 
were combined. Electrolyte disturbances were still common, and low sodium levels were found in 11 
of the 25 patients (44%) and low potassium levels were found in 6 of the 25 patients (24%). Elevated 
urinary ACR of non-nephrotic range was found in four patients, three of them had elevated ACR at 
the time of the biopsy and at follow-up the levels had increased. In one patient the elevated ACR was 
new and measured only 5.1 mg/mmol.  
When studying possible biochemical or morphological predictors of a decrease in eGFRCr, low serum 
sodium or severe glomerular enlargement in the biopsy at baseline was significantly correlated with a 
larger decrease in eGFR, however, due to the limited sample size, these associations might not be 
valid and need to be confirmed in larger cohorts.    
 
4.3 STUDY III (SRI LANKA) 
Eleven male patients with a mean age of 48 ± 11 (range 27-61) years with a history of rice paddy 
farming were included in the study. Mean BMI was 20 (range 16-28) kg/m², and mean blood pressure 
was 122/78 mmHg.  
4.3.1 Questionnaire 
Three of the participants had a family history of CKD. The patients reported that they had been 
farmers between 7 and 40 years, and all reported exposure to multiple pesticides and fertilizers. Mean 
liquid intake was 4.3 liters per day and water was the main liquid intake. Few patients used analgesics, 
but the majority of participants reported prior use of traditional herbal medicines (Ayurvedic 
medicines). Three participants used antihypertensive medicines and two participants were on 
potassium-chloride supplements.   
4.3.2 Biochemical characteristics 
Mean serum creatinine was 184 ± 50 µmol/L (2.08 ± 0.56 mg/dl), and the mean eGFRCr was 40 ± 14 
(range 21-70) ml/min/1.73m². Electrolyte disturbances in serum were common, and low sodium was 
found in one, low potassium in two, and low magnesium in four patients. Uric acid levels were 
elevated in six patients. Serological tests for Hantavirus were positive for Hantaan virus IgG in eight 
patients (IgM negative), indicating previous infection. Only three patients had elevated urine ACR (all 
three <500mg/g). In the two patients with hypokalemia, urine samples indicated renal potassium 
losses and in 10 patients the urine test indicated renal wasting of magnesium. Urinary heavy metals 
were all below toxic levels.  
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4.3.3 Renal morphology 
All 11 participants underwent renal biopsy and the biopsies contained 7-29 glomeruli. The 
morphological findings were more heterogeneous compared to the morphological findings in Studies I 
and II. A summary of the main findings is reported in the text below. 
4.3.3.1 Light microscopy and immunofluorescence  
Global glomerulosclerosis of varying degree (8-75% of included glomeruli) (Figure 13A, 13B, 13D) 
and glomerular hypertrophy were found in all patients (Figure 13A). Signs of glomerular ischemia 
(thickening of Bowman’s capsule and/or wrinkling of capillaries) were observed in seven patients; in 
three of these cases the signs of ischemia may be explained by a concurrent moderate thickening of 
the arterial intima. Bowman’s capsule showed focal cystic dilatation in three patients (Figure 13B). 
Tubular atrophy was mostly mild, and interstitial fibrosis was mostly mild to moderate (Figure 13C, 
13D). Interstitial inflammation of varied greatly, from no inflammation to severe (Figure 13A, 13B, 
13D). In three patients, tubulitis was observed, and in two patients clusters of neutrophil granulocytes 
were observed in the tubular lumina, indicating acute pyelonephritis. In most cases, arteries were  
 
  
Figure 13: Light microscopy findings in Study III. Glomerular hypertrophy (arrow in A) and global glomerulosclerosis (stars 
in A, B and D) were observed in all patients. Cystic dilation of Bowman’s capsule was found in some patients (arrow in B). 
Tubular atrophy and interstitial fibrosis (C, D) were mostly mild to moderate, but interstitial inflammation was of greatly 
varying degree from no inflammation (A) to mild (D), moderate (B), and severe inflammation. Arteries were in most cases 
normal or mildly changed (arrows in D). A: PAS staining from patient 2, bar= 100 µm. B: HE staining from patient 7, bar= 
200 µm. C: Ladewig staining from patient 10, bar= 100 µm. D: Ladewig staining from patient 4, bar= 100 µm. 
normal or only mildly changed, but in three cases the intimal thickening was moderate. Mild to 
moderate arteriolar hyalinosis was observed in most patients. IFL were all negative, thus not showing 
any signs of immune-complex disease. The individual biopsy results showed that six patients as main 
A B 
C D 
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findings showed a combination of glomerulosclerosis, glomerular enlargement, and mild to moderate 
tubulointerstitial damage, i.e. findings similar to MeN as described in Studies I and II. In two patients 
the morphology diagnosis was chronic tubulointerstitial nephritis, in two other patients the findings 
suggested acute and chronic pyelonephritis and in the last patient the morphology indicated 
nephrosclerosis.      
4.3.3.2 Electron microscopy 
Segmental podocytic foot-process effacement was seen in two patients (Figure 14A) and most patients 
showed an increased number of vacuoles or lipofuscin-like bodies in the podocyte cytoplasm (Figure 
14B). No electron-dense immune complexes were observed.   
  
Figure 14: Transmission electron microscopy images from Study III. Podocytic foot-process effacement was seen in two 
patients (A, patient 4). Nine patients had increased numbers of vacuoles and/or lipofuscin-like bodies (arrows in B, patient 6) 
in the podocyte cytoplasm. C=capillary space. N=nucleus. PC=podocyte. Bars: A=2µm, B=5µm. 
 
4.4 STRENGTH AND LIMITATIONS OF THE STUDIES  
The main strength of the studies is the detailed description of groups of patients with CKDu including 
detailed kidney morphology in combination with thorough clinical examinations, and biochemical 
data from urine and blood samples. Another important strength of the studies is the similarities in 
study design, which enable a comparison of CKDu in the different regions. In all three studies the 
renal biopsies were handled in a similar manner and were stained according to the same protocols in 
the same renal biopsy laboratory, thus ensuring that the preparation of the biopsy slides for 
pathological evaluation were consistently of high quality. Evaluations of the renal specimens was 
conducted by two senior renal pathologists according to a standardized protocol, partly based on the 
Banff criteria used for renal allograft pathology (95, 96). To ensure reliability and consistency, most of 
the biochemical tests (urine and blood samples) were analyzed at accredited laboratories such as the 
Karolinska University Hospital Laboratory and the ALS Scandinavia Laboratory.   
A limitation in all of the studies is the small number of participants. However, the studies were 
intentionally designed to study a small number of patients, because the renal biopsy procedure is an 
invasive procedure with a non-negligible risk of complications. A severe complication would 
probably have added more to the disease burden in patients from these poverty-stricken communities. 
A B 
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Another limitation is that there was no control group with regards to the biochemical and exposure 
data from the questionnaires. The ideal study would have had a control group with CKD of other 
known causes (e.g. diabetes, hypertension or glomerulonephritis) matched for age, sex and eGFR, and 
healthy controls would also have been interesting to include. However, since the sample size was 
small, conclusions regarding differences may be difficult to interpret. Another limitation of the studies 
is the selection of patients, which was not conducted in a randomized way in the population. The 
patient selection in Study I was performed by local nephrologists by asking patients attending a kidney 
out-patient clinic matching the inclusion and exclusion criteria if they wanted to participate in the 
study. This selection process may have caused a selection bias. In Study II, patient recruitment was 
more structured and all patients attending an occupational and environmental medicine out-patient 
clinic during a 12 month-period and who fit the inclusion/exclusion criteria were invited to the study. 
A total of 50 patients were invited, of whom 19 patients agreed to participate (20 patients did not 
respond). By only inviting patients from an occupational and environmental clinic, the included 
participants would, however, not reflect a cross-section of the whole CKDu population. In Study III, 
patients already planned for clinical renal biopsy and who were eligible according to the inclusion 
criteria were asked to participate. However, no record was kept on how many potential participants 
were invited, which increases the risk of selection bias.      
All studies were conducted outside of harvest season and this could be a limitation, because 
occupational exposure has been suggested to be of importance in the development of the disease. 
However, to perform kidney biopsies in a safe manner hospitalization is required and the patients have 
to refrain from hard physical activity for 1-2 weeks post biopsy. Thus, obtaining biopsies during 
harvest season was not possible, since the participants would lose their income or even employment 
during this period.           
 
5 COMPARISON AND DISCUSSION OF STUDIES I-III 
Patient characteristics and clinical data were quite similar between the studies (Table 3). Noteworthy 
differences were that a higher percentage of patients in Study I used NSAIDs regularly. Patients in 
Study II were generally younger, did not use any hypertensive medicines, used less herbal medicines, 
and reported a lower exposure to agrochemicals than in the other studies. Furthermore, patients in 
Study III were older, had a lower BMI (probably due to lower muscle mass), and did not use NSAIDs. 
In summary, Study II was the youngest and “healthiest” study group suggesting that any age-related 
changes in the kidney tissue, such as changes secondary to general arteriosclerosis are probably less 
frequent in this group. Study III had the oldest participants, and the majority had been smokers.   
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Table 3: Patient characteristics in Study I (El Salvador), Study II (Nicaragua), and Study III (Sri Lanka). Results are 
presented as the mean ± SD (range) or cases (%). 
 Study I, n=8 Study II, n=19 Study III, n=11 
Age (years) 44 (22-57) 33 (24-54) 48 (27-61) 
Height (m) 1.68 (1.55-1.78) 1.68 (1.52-1.90) 1.66 (1.57-1.75) 
Weight (kg) 73 (55-100) 71 (50-100) 56.6 (46.9-77) 
BMI (kg/m²) 26 (20-35) 25 (19-37) 20 (16-28) 
Systolic BP (mmHg) 112 (100-130) 121  (105-133) 122 (97-160) 
Diastolic BP (mmHg) 71  (60-80) 75  (56-88) 78 (58-90) 
Kidney length (mm) - 98  (87-109) 87 (78-98) 
Years working in agriculture 32 (8-44) 15 (3-40) 24 (3-40) 
Agrochemical exposure 8 (100%) 7 (37%) 11 (100%) 
Current liquid intake (L/day) 3.9 (2.5-5) 5.3 (1.0-10) 4.3 (3.0-6.0) 
Liquid intake a work day (L) - 9.0 (3.4-15.1) - 
Hypertensive medicines 3 (38%) 0 (0%) 3 (27%) 
Regular NSAID use 5 (63%) 6 (32%) 0 (0%) 
Regular paracetamol use 5 (63%) 10 (53%) 2 (18%) 
Ever used herbal medicines 5 (63%) 1 (5%) 7 (64%) 
Ever smoked 4 (50%) 6 (32%) 8 (73%) 
Pack years 5.8 (0-40) 0.9 (0-10.5) 1.6 (0-6.2) 
 
5.1 BLOOD CHARACTERISTICS 
The results of the blood tests were rather similar in all three studies (Table 4), especially with regards 
to serum electrolyte changes. eGFR, was somewhat similar in Studies I and III, but was significantly 
higher in Study II. 
Table 4: Blood test results in Study I (El Salvador), Study II (Nicaragua), and Study III (Sri Lanka). Results are presented as 
the mean (range) or cases (%). 
Serum/plasma 
 Study I, n=8 Study II, n=19 Study III, n=11 
Creatinine (µmol/L) 172 (100-241) 146 (92-222) 184 (120-267) 
eGFRCr (ml/min/1.73m²) 46 (27-79) 57 (33-96) 40 (21-70) 
eGFRCystC (ml/min/1.73m²) 40 (23-60) 57 (38-109) 38 (20-66) 
eGFRCr+CystC (ml/min/1.73m²) 42 (24-67) 56 (36-96) 38 (20-66) 
Sodium (mmol/L) 136 (122-141) 137 (133-139) 140 (134-147) 
Low Sodium (<137 mmol/L) 2 (25%) 9 (47%) 1 (9%) 
Potassium (mmol/L) 3.3 (2.4-4.7) 3.8 (2.2-4.9) 4.3 (2.2-6.3) 
Low Potassium (<3.5 mmol/L) 6 (75%) 4 (21%) 2 (18%) 
Magnesium (mmol/L) 0.74 (0.44-1.01) 0.70 (0.51-0.82) 0.70 (0.43-0.88) 
Low Magnesium (<0.7 mmol/L) 4 (50%) 7 (37%) 4 (36%) 
Uric acid (µmol/L) 457 (375-572) 443 (264-715) 420 (201-583) 
High Uric acid (> 416 µmol/L) 6 (75%) 11 (58%) 6 (55%) 
Renin (ng/L or mIU/L) 94 (29-352) ng/L 68 (18-615) mIU/L 28 (3-90) mIU/L 
High Renin (>33 ng/L or >40mIU/L) 7 (88%) 8 (42%) 2 (18%) 
Aldosterone (pmol/L) 926 (211-2520) 265 (86-1080) 364 (94-953) 
High Aldosterone (>650 pmol/L) 4 (50%) 1 (5%) 2 (18%) 
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Low serum levels of sodium, potassium and magnesium were a frequent finding in patients in all three 
studies. Generally, in CKD patients, both hypo and hypernatremia may occur, in most cases due to 
other comorbidities or medications (97). Serum potassium and magnesium levels usually increases 
gradually when GFR is declining and both hyperkalemia and hypermagnesemia are frequent findings 
in advanced stages of CKD (98, 99). Moranne et al, reported that already in CKD stage 3, i.e. GFR 
30-59 ml/min/1.73m², hyperkalemia can be found in approximately 4-14% of patients, and with 
further deteriorating kidney function, the prevalence of hyperkalemia gradually increase to >40% in 
patients with GFR <20 ml/min/1.73m² (100) and, in fact, other studies have reported an even higher 
prevalence (98). Thus, the low levels of serum potassium (Figure 15) and magnesium found in our 
studies differ from what is normally seen in patients with CKD.  
 
 
 
Figure 15: The association between serum 
potassium and eGFRCr+CystC in Study I 
(squares), Study II (red triangles), and Study 
III (blue dots). Dotted lines indicates the 
normal reference value for serum potassium, 
3.5-5.0 mmol/L.   
 
 
 
Our findings regarding the serum electrolytes are consistent with other reports from patients with 
MeN in Central America. Herrera et al (45) reported from a cohort of 46 participants in El Salvador 
with CKDu who also underwent renal biopsy (101) that 47.8% had hyponatremia, 30.4% 
hypokalemia, and 19.6% had hypomagnesemia. In cross-sectional studies similar electrolyte 
disturbances have been reported. For example Kupferman et al reported that among 242 individuals 
from a MeN hot spot area 10% of the CKD patients had hyponatremia, 9% had hypokalemia and 25% 
had hypomagnesemia (37). The similarities in electrolyte disturbances seen in Study III from Sri 
Lanka support the hypothesis that CKDu in Central America and Sri Lanka are related diseases with 
similar pathophysiology.  
Elevated serum levels of uric acid were seen in 55-75% of the participants in the three studies and are 
probably secondary to the reduced GFR because hyperuricemia is a prevalent finding in patients with 
CKD. The prevalence of hyperuricemia has been reported from a US cohort to be approximately 30% 
in patients with GFR 60 ml/min/1.73m² and to increase to almost 80% in patients with GFR 30 
ml/min/1.73m² (102). The prevalence of elevated uric acid is somewhat higher in our studies 
compared to the US data, but our sample size is small and might not be comparable to a population 
study from another country. Furthermore, differences in diet and genetics may influence uric acid 
levels (103).  
 
 34 
 
5.2 URINE CHARACTERISTICS 
Results from the urine samples were also quite similar in Study I, Study II, and Study III (Table 5). 
Only a minority of the participants in each study had elevated ACR levels, and in all cases the 
albuminuria was of non-nephrotic range. Even though an exclusion criterion in the studies was 
proteinuria above 3.5, 3.0, and 1.0 g per 24 h respectively in the studies, the majority of the patients 
did not have albuminuria at all, and the individuals with increased ACR all had values ≤91 mmol/L 
(i.e. approximately <1 g/24 h). The low or absent albuminuria in MeN reported in epidemiological 
studies (19-21), is in agreement with our findings. In previous Sri Lankan studies of CKDu, 
proteinuria/albuminuria has also been described as low-range (53). However, it should be noted that 
most epidemiological studies used dip-stick albuminuria as a screening method. In Study III, we used 
the exclusion criterion of proteinuria >1 g /24 h to be able to study a group of patients comparable to 
those of Studies I and II from Central America. Indeed, the results show that in Study III the majority 
of the included patients with CKDu also did not have any albuminuria, and the four patients who did 
have albuminuria all had levels ≤47.2 mg/mmol (i.e. approximately <0.5 g/24 h). Similar results have 
been reported from another biopsy study of patients with MeN in El Salvador in which only 1 of 46 
participants displayed proteinuria >1 g/24 hours (45). In our studies, most participants had increased 
levels of urinary biomarkers for tubular injury, A1M and NAG (104, 105). Other reports from both 
Central America and Sri Lanka have also described a high prevalence of tubular injury markers in 
urine (45, 61, 62). 
Table 5: Urine spot sample test results in Study I (El Salvador), Study II (Nicaragua), and Study III (Sri Lanka). Results are 
presented as the mean (range) or cases (%). 
Urine Study I, n=8 Study II, n=19 Study III, n=11 
ACR (mg/mmol) 14.5 (0.1-89.1) 7.2 (0.1-91.4) 7.2 (0.1-47.2) 
High ACR (>3.4 mg/mmol) 2 (25%) 2 (11%) 4 (36%) 
A1M/creatinine (mg/mmol) 6.3 (0.5-13.4) 3.1 (0.3-15.9) 5.2 (0.8-14.5) 
High A1M/creatinine (>0.7 mg/mmol) 7 (88%) 15 (79%) 10 (91 %) 
NAG (nkat/mmol) 13 (4-19) 8 (1-21) - 
High NAG (>8 nkat/mmol) 6 (75%) 8 (42%) - 
Uric Acid (mmol/L) 1.2 (<0.3-2.4) 1.6 (0.5-3.9) 1.3 (0.5-2.6) 
Sodium (mmol/L) 64 (23-90) 119 (21-254) 104 (36-299) 
FENa (%) 1.3 (0.5-2.6) 1.6 (0.9-3.0) 1.8 (0.5-3.3) 
Potassium (mmol/L) 40 (15-76) 33 (4-61)b 27 (5-50) 
Potassium/creatinine 5.5 (3.2-9.7) 4.3 (2.7-8.9) 3.3 (1.1-3.7) 
FEK (%) 30 (15-71) 17 (8-32) 15 (8-25) 
Magnesium (mmol/L) - - 2.1 (1.1-3.7) 
FEMg - - 11 (4-17) 
 
As in Central America, the findings in urine dip-stick and sediment in most CKDu cases from Sri 
Lanka were bland. However, in Study III one patient had a few granular casts and one patient had 
slightly increased red blood cell count in urine. Urine cultures were negative in all but one patient in 
our three studies, and other studies of MeN patients have also reported negative urine cultures (45). In 
Sri Lanka, there is to our knowledge as of yet no published report on the findings in urine sediment or 
urine cultures in patients with CKDu.    
Mean urine uric acid levels were relatively similar in all three studies and were within normal range. 
Urine uric acid crystals were found in one patient (with serum uric acid 650 mmol/L) in Study II.   
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Interestingly, signs of renal electrolyte wasting (sodium, potassium and magnesium) were found in the 
urine of a number of patients from all three studies (Table 5), and this wasting was probably 
responsible for or contributed to the low electrolyte levels seen in serum. Urinary sodium excretion is 
normally 40-220 mmol/24h, but the secretion of sodium is difficult to interpret because it is highly 
variable depending on e.g. dietary salt intake, serum glucose etc. Our results are also limited to spot 
urine samples. Nevertheless, out of the 12 patients with low serum sodium in our studies, and who 
were non-symptomatic and presumably euvolemic, 10 had urine sodium excretion > 30 mmol/L, 
which could indicate renal salt wasting (106).  
The normal range for urinary potassium secretion is 25-125 mmol/24h, but in hypokalemic patients, 
the secretion normally declines to 5-25 mmol/24h. In hypokalemic patients, the potassium-creatinine 
ratio in a spot urine sample should be <1.5, and the fractional excretion of potassium (FEK) should be 
<10%, and higher ratios indicate renal potassium losses (107, 108). In the three studies, hypokalemia 
was found in 12 patients, and these patients had a mean urinary potassium concentration of 38 (range 
12-76) mmol/L, and all 12 had a potassium-creatinine ratio >1.5 and FEK >10% indicating renal 
potassium wasting.  
Urinary magnesium was measured in Study III and interestingly the fractional excretion of 
magnesium, FEMg, was high in all patients (i.e. >4%) indicating renal magnesium wasting (109, 110). 
However, it has been shown previously that the FEMg may increase in moderate CKD as a way to 
compensate for the decreases in GFR and to keep plasma magnesium levels within the normal range 
(99). Four of the 11 patients in Study III had hypomagnesemia indicating that at least in these patients 
the excretion of magnesium was excessive.  
In Study II, 24 h urine was collected and showed that almost half of the participants had polyuria, i.e. 
24 h urine volume >3 L. Similar result with polyuria and electrolyte losses in urine have also been 
reported by Herrera et al in El Salvador (45). The combination of polyuria and urinary electrolyte 
levels further indicates renal electrolyte wasting, probably due to tubulointerstitial damage, and this 
might explain the low levels of electrolytes found in plasma. An aspect that needs to be considered 
regarding the polyuria is that patients diagnosed with CKD in MeN-endemic areas are aware of the 
hypothesis regarding dehydration and probably have been instructed by physicians and/or the media to 
drink more water, thus the high urine output might be due to increased water intake.   
In Sri Lanka, published data about urine electrolytes is scarce. Jayatilake et al studied metals and 
heavy metals in urine and reported normal levels of sodium, magnesium, and potassium (57); however 
the serum concentrations of the ions were not reported. 
Serum osmolality was measured in Study II and was normal in 16 of the 19 patients. The three 
remaining patients had values between 304 and 316 mosmol/kg. Urine osmolality was measured only 
in Study III, and the only two values that were not within the reference range were those of the two 
patients with morphological signs of pyelonephritis at 126 and 139 mosmol/kg, respectively. 
However, both serum and urine osmolality samples had been frozen and stored, which might give 
false high values, especially in serum (111), thus limiting the interpretation of these results.   
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5.3 KIDNEY MORPHOLOGY  
The clinical characteristics of the patients with low-grade or absence of proteinuria and few other 
significant symptoms or laboratory findings led many clinicians and researchers to believe that MeN 
was a tubulointerstitial nephritis. However, before 2012 no information regarding the renal 
morphology of MeN had been reported or published in the scientific literature. In fact, in both El 
Salvador and Nicaragua, only a few clinical renal biopsies had been performed before 2012, to some 
extent due to financial limitations, but mainly due to a lack of pathologists specialized in renal 
pathology.  
The aim of Studies I and II was to investigate and report the renal morphology in patients with MeN in 
detail, together with a clinical and biochemical description of the patients. Our research group 
conducted the first study of renal biopsies together with clinical and biochemical data from eight 
patients with suspected MeN in El Salvador in 2012 (Study I), and the results were published in 2013. 
We found a unique renal morphology in patients with MeN, characterized by chronic damages to both 
glomerular and tubulointerstitial compartments with extensive glomerulosclerosis, glomerular 
hypertrophy, and mild to moderate tubulointerstitial changes with mostly normal vessels (112).  
In 2014, another study of biopsies from patients with MeN in El Salvador was published by López-
Marín et al and described the morphological findings from 46 patients with CKD stage 2-3 (i.e. GFR 
30-90 ml/min/1.73m²). The authors concluded the findings to be a chronic tubulointerstitial 
nephropathy with secondary glomerular damage; however, they also reported substantial chronic 
glomerular changes. Furthermore, they also reported that 37% of the patients had ≤ 5% interstitial 
fibrosis, 87% had <25 % tubular atrophy, and 89% had <25 % interstitial inflammation, i.e. the results 
were very similar to our findings in Studies I and II (Table 6), even though the authors’ conclusions 
with regard to the morphology (chronic tubulointerstitial nephropathy with secondary glomerular 
damage) differs from ours. 
It is well known that interstitial changes can cause glomerular changes and vice versa. The two 
pathologists in our studies have made the assessment that the tubulointerstitial changes seen in our 
studies are likely to be too mild to alone cause the rather extensive glomerular changes. They have 
made this assessment from their experience as pathologists evaluating other tubulointerstitial renal 
diagnoses; however a more systematic comparison with other tubulointerstitial diseases has, as of yet, 
not been made. From our studies, we cannot conclude whether the primary lesion is tubulointerstitial 
or glomerular, but the morphology does not correspond to a classic chronic tubulointerstitial nephritis, 
where glomeruli usually are unremarkable until advanced stages of the disease (113). To some, the 
discussion of whether the renal morphology in MeN (and CKDu in Sri Lanka) is a tubulointerstitial 
disease or not, might seem irrelevant. Nevertheless, since the etiology of the disease is still not fully 
known, it is important to be objective and to report all morphological findings as they may be of 
importance in the pathophysiological mechanisms behind the disease.  
In Sri Lanka, one of the first reports of renal biopsy findings was published in 2011 (53), and since 
then a number of studies have been published. They describe a tubulointerstitial disease with 
interstitial fibrosis and tubular atrophy as the main finding, but in addition, they also report glomerular 
changes, such as global and segmental sclerosis, ischemia induced glomerular changes, etc. The main 
difference between studies conducted in Central America and Sri Lanka is that patients in the Sri 
Lankan biopsy studies have been selected by screening for dip-stick albuminuria, thus deselecting 
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individuals with CKDu without albuminuria. Therefore, Study III was designed to include Sri Lankan 
patients with CKDu with low-range or without albuminuria.    
5.3.1 Comparison of Studies I, II and III  
In Table 6, a summary of the morphological findings in Studies I, II and III is presented. When 
comparing Studies I and II (Table 6) there are some interesting similarities and differences. The main 
differences between Studies I and II are that the percentage of glomerulosclerosis was lower and the 
tubulointerstitial changes were less pronounced in Study II. These findings suggest that MeN at earlier 
stages (better kidney function) has a similar morphology but with less chronic changes. Interestingly, 
glomerular hypertrophy was more pronounced in Study II even though subjects in Study II had better 
renal function, indicating that glomerular enlargement might be an early pathophysiological or 
compensatory mechanism in MeN. Similar findings, with a higher percentage of glomerular 
hypertrophy in patients with better renal function, have also been reported by López-Marín et al in 
their biopsy study in El Salvador (101). Glomerular enlargement might be compensatory due to the 
loss of functioning nephrons or low nephron count due to other causes (114), but can also be a result 
of chronic ischemia (115). The glomerular enlargement might also increase the risk for the 
development of segmental sclerosis, which has been observed in our studies (116).  
Table 6: Renal biopsy results from Study I (El Salvador), Study II (Nicaragua), and Study III (Sri Lanka). Results are 
presented as the mean ± SD (range) or cases (%). 
 Study I, n=8 Study II, n=16 Study III, n=11 
Mean number of glomeruli  20 ± 6 (10-30) 17 ± 7 (7-28) 17 ± 6 (7-29) 
    
Light microscopy     
Glomerular changes n=8 n=16 n=11 
Globally sclerosed glomeruli (%) 52 ± 17 (29-78) 38 ± 21 (7-70) 43 ± 20 (8-75)  
% globally sclerosed glomeruli    
      <25% 0 (0%) 4 (25%) 2 (18%) 
      25-50% 5 (63%) 7 (44%) 4 (36%) 
      >50% 3 (38%) 5 (31%) 5 (45%) 
Segmental scleroses 2 (25%) 2 (13%) 0 (0%) 
Glomerular hypertrophy    
     0 0 (0%) 0 (0%) 0 (0%) 
     1 3 (38%) 0 (0%) 6 (55%) 
     2 3 (38%) 11 (69%) 4 (36%) 
     3 2 (25%) 5 (31%) 1 (9%) 
Wrinkled GBM / Periglom. fibrosis    
     Yes 8 (100%) 15 (94%) 7 (64%) 
     No 0 (0%) 1 (5%) 4 (36%) 
    
Tubulointerstitial changes n=8 n=16 n=11 
Tubular atrophy     
      No, 0-5% 0 (0%) 1 (6%) 0 (0%) 
      Mild, 6-25% 4 (50%) 13 (81%) 10 (91%) 
      Moderate, 26-50% 4 (50%) 2 (13%) 1 (9%) 
      Severe, >50% 0 (0%) 0 (0%) 0 (0%) 
Interstitial fibrosis     
     No, 0-5% 0 (0%) 1 (6%) 0 (0%) 
     Mild, 6-25%  3 (38%) 8 (50%) 6 (55%) 
     Moderate, 26-50% 4 (50%) 7 (44%) 4 (36%) 
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     Severe, >50% 1 (13%) 0 (0%) 1 (9%) 
Interstitial inflammation     
     No, 0-5% 1 (13%) 2 (13%) 2 (18%) 
     Mild, 6-25% 4 (50%) 12 (75%) 5 (45%) 
     Moderate, 26-50% 3 (38%) 2 (13%) 2 (18%) 
     Severe, >50% 0 (0%) 0 (0%) 2 (18%) 
Vascular changes    
Intimal thickening n=8 n=15 n=10 
     0 6 (75%) 11 (73%) 5 (50%) 
     1 2 (25%) 3 (20%) 2 (20%) 
     2 0 (0%) 1 (7%) 3 (30%) 
     3 0 (0%) 0 (0%) 0 (0%) 
Smooth muscle hyperplasia n=8 n=15 n=10 
     0 1 (13%) 5 (33%) 6 (60%) 
     1 5 (63%) 6 (40%) 4 (40%) 
     2 2 (25%) 4 (27%) 0 (0%) 
     3 0 (0%) 0 (0%) 0 (0%) 
Arteriolar hyalinosis n=8 n=16 n=11 
     0 5 (63%) 11 (69%) 1 (9%) 
     1 3 (38%) 3 (19%) 7 (64%) 
     2 0 (0%) 2 (13%) 3 (27%) 
     3 0 (0%) 0 (0%) 0 (0%) 
    
Electron microscopy n=8 n=16  n=11 
GBM thickness (nm) 419 ± 93 (340-625) 441 ± 63 (333-566) 307 ± 39 (259-349) 
Podocyte foot processes (slits/µm GBM) 1.3 ± 0.3 (0.9-1.7) 1.0 ± 0.5 (0.1-1.7) 1.5 ± 0.2  (1.2-1.8) 
Podocyte foot process effacement    
     No (normal) 5 (63%) 7 (44%) 11 (100%) 
     Segmental effacement 3 (38%) 4 (25%) 2 (18%) 
     Widespread effacement 0 (0%) 5 (31%) 0 (0%) 
Endothelial cells    
     Normal 8 (100%) 10 (62%) 11 (100%) 
     Swollen 0 (0%) 6 (38%) 0 (0%) 
Podocyte cytoplasm inclusions    
     Yes 6 (75%) 12 (75%) 9 (82%) 
     No 2 (25%) 4 (25%) 2 (18%) 
 
In Study III, the glomerular changes were not as pronounced as in Studies I and II, especially with 
regards to glomerular enlargement and signs of glomerular ischemia (wrinkled GBM and/or 
thickening of Bowman´s capsule). Tubular atrophy and interstitial fibrosis in Study III were relatively 
similar to the results in Studies I and II, but the interstitial inflammation was more diverse and some 
patients displayed severe inflammation, which was not observed in Studies I and II. Vascular changes 
were also more common in Study III, which might be due to the older age of the participants.  
When comparing Study III (Sri Lanka CKDu) with Studies I and II (MeN/CKDu in Central America), 
the findings at the group level are quite similar. However, when studying the individual biopsies, the 
biopsies from Study III display a much more mixed morphology compared to the studies from Central 
America where the findings have been more homogenous. Six of the eleven participants in Study III 
had a MeN-like morphology, i.e. findings very similar to the findings in Studies I and II, supporting 
the hypothesis that the two endemics are related diseases. However the five remaining biopsies 
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showed chronic tubulointerstitial nephritis, pyelonephritis, and nephrosclerosis. One could speculate 
that these biopsies represent different stages or a variation of the disease, or one could hypothesize 
that the CKDu endemic in Sri Lanka could have several different etiologies. Nanayakkara et al 
reported that in some biopsies from CKDu patients they found massive interstitial inflammation that 
they suggested to be the primary lesion in CKDu (64). We also found severe interstitial inflammation 
in two patients in the Sri Lankan study, but these specimens also displayed chronic tubulointerstitial 
changes indicating a more chronic state. A repeated inflammatory state might explain these findings. 
The results in Study III with some of the individual biopsy results indicating pyelonephritis, despite 
negative urine cultures, and chronic tubulointerstitial nephritis, call for more research focusing on 
infectious and inflammatory diseases. 
In summary, the majority of the CKDu patients in our study in Sri Lanka (Study III) had a similar 
renal morphology as the CKDu patients we studied in Central America (Studies I and II), supporting a 
common diagnostic entity and thus also a common etiology. However, glomerular changes were less 
pronounced in Sri Lanka and the Sri Lankan patients had more mixed morphology and more 
frequently displayed interstitial inflammation and vascular pathology. Additional and larger biopsy 
studies are needed to elucidate these differences.   
 
6 DISCUSSION REGARDING POSSIBLE ETIOLOGIES 
Many different hypotheses regarding possible etiologies and contributing factors in the development 
of MeN in Central America and CKDu in Sri Lanka have been proposed, but as of yet no definite 
etiology or pathophysiological mechanism has been scientifically proven in any of the regions. 
Proposed etiologies include pesticides, heavy metals, infections, drinking locally brewed alcohol, 
genetic factors, and nephrotoxic drugs. Still, the leading hypothesis regarding etiology is occupational 
heat exposure causing repeated volume and salt depletion resulting in kidney damage that eventually 
develops into CKD (85, 117). A summary of the evidence for these hypotheses and their relation to 
our findings will be presented in this chapter.  
6.1 DEHYDRATION / HEAT STRESS / SALT DEPLETION 
Complications due to heat exposure such as heat stroke, heat collapse, heat rashes and heat fatigue are 
known problems among people working in warm environments. To measure heat exposure during 
work outside wet-bulb globe temperature (WBGT) is usually used, because this measurement takes in 
to account temperature, humidity, wind speed, as well as solar radiation. The Occupational Safety and 
Health Administration (OSHA) in the US has guidelines for how much rest a worker needs per hour 
during hard physical work in hot climates, to avoid being at risk for heat exposure related illnesses. 
The heat exposure threshold limit values in these guidelines are 25°C for continuous work, but at 
26°C there is a need for 15 min of rest each hour, at 28°C the worker needs 30 min of rest each hour, 
and at 30°C there is a need for 45 min of rest each hour (118). 
Several studies have reported an increase in hospital admissions in renal diagnoses during high 
temperatures and heat waves, e.g. in Australia (119) and Rhode Island (120). In Taiwan, it was 
reported that the relative risks of hospital admissions due to a renal diagnosis are 1.45 (95% CI 1.27–
1.64) at 30°C compared to 25°C (the temperature with the lowest incidence of hospital admissions). A 
study from Brisbane, Australia, reported an increased number of renal disease emergency hospital 
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admission among children during heat waves, and interestingly, tubulointerstitial nephritis was one of 
the most frequent diagnoses according to this study (121). Chronic interstitial nephritis has also been 
described as a consequence of heatstroke in an old publication studying mine workers in South Africa 
(122). Another study indicating an association between heat exposure and kidney disease was 
published in 2012, and that study reported a significant association between self-reported occupational 
heat stress and renal disease diagnosis among 37816 male workers in Thailand (OR = 1.48, 95% CI 
1.01–2.16) (123).  
Repeated subclinical or undiagnosed acute kidney injury (AKI) due to heavy work in a hot climate is 
one of the suggested main mechanisms in the pathophysiology of MeN in Central America. Several 
different causes may be involved, including dehydration/volume depletion, rhabdomyolysis, RAAS 
activation, salt depletion due to sweating, but also exposure to nephrotoxins. In the last decades there 
has been growing body of evidence indicating that episodes of AKI per se are risk factors for the 
development of CKD (124, 125). A recent study from the UK reported that patients with recovery of 
renal function after one AKI episode actually have a subsequent increased risk for decreasing kidney 
function over a ten-year period (126).  
In Study II, the extreme conditions during sugarcane harvest are evident in the amount of liquids 
consumed during a work day (Results, Table 3), when daily liquid almost doubles and almost half of 
the participants reported a daily intake of > 10 liters. Salt losses due to increased sweating in 
combination with a large intake of water might play a role in the development of the electrolyte 
disturbances seen in the patients. However, in all three studies, samples were collected outside of 
harvest season indicating a more chronic condition.   
Occupational studies of sugarcane workers in Central America also reveal their difficult working 
conditions. In a study of sugarcane workers in Costa Rica, WBGT and workload were assessed during 
workdays. The results showed that after 9:15 a.m. the workers’ heat exposure was of such extent that 
according to OSHA guide lines the workers should only work 15 minutes per hour to avoid heat-
related health risks (25). The frequency of heat-related symptoms among 106 sugarcane harvesters in 
Costa Rica compared to non-harvesters was evaluated by Crowe et al. They reported that heat and 
dehydration symptoms were significantly more frequent among harvesters and that with increasing 
heat exposure symptoms became more prevalent (127). Another study by Garcia-Trabanino et al, 
measured the heat index during harvest in three different sugarcane plantations in El Salvador and 
found that a heat index of 103°F (39.4°C), considered “high risk” according to OSHA was reached 
already at 7:00-7:30 a.m. and that a heat index of 115°F (46°C), considered “very high to extreme”, 
was reached between 7:30 and 10:00 a.m. (44).  
Among sugarcane workers in Central America, cross-shift studies have indeed demonstrated that 
many sugarcane workers have an increase in serum creatinine levels during a workday (44) and 
during/after the harvest season (41-43) indicating an occupation-associated decrease in eGFR /kidney 
function.  
Interestingly, two studies of agricultural workers conducted in warm regions outside of known CKDu 
areas have reported that a high percentage of workers have a serum creatinine increase during a work 
shift equivalent to AKI. Santos et al reported from 28 sugarcane workers in Brazil that 19% of the 
workers had a serum creatinine increase during a work shift consistent with AKI (128). Moyce et al 
(2017) studied 283 agricultural workers in California during the summer and found that 12% 
developed changes between pre and post-shift serum creatinine consistent with AKI. In the latter 
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study, heat strain was assessed in the participants by measuring core body temperature and pulse rate, 
and in logistic regression models heat strain was associated with a higher risk of AKI, while changes 
in body mass indicating volume depletion did not show any statistically significant association (129).  
If AKI can develop in a significant number of workers, as shown in these studies, after only one work 
shift, it is likely that repeated kidney injury will occur during harvest season, further increasing the 
risk of developing CKD.     
An intervention program based on OSHA’s Water.Rest.Shade. initiative (130) was carried out during 
a five-month harvest period in a sugarcane plantation in El Salvador. The intervention started half-way 
through harvest season and included approximately 60 workers who were provided with water in 
individual backpacks, scheduled rest periods, mobile shaded rest areas, and lighter and more 
ergonomically designed machetes. Anthropometric data, blood and urine samples, and questionnaires 
were collected before and after the intervention along with daily temperatures (WBGT) and data 
regarding productivity. The first report from this intervention was published in 2016 by Bodin et al 
(131) and the authors found that workers drank 25% more water during the intervention and that heat 
stress-related symptoms decreased. Actually, productivity increased during the intervention, indicating 
that better working conditions can maintain or even increase productivity on sugarcane plantations. A 
recent publication presents the biochemical results from the intervention group compared to a non-
intervention group (132). A cross-shift decrease in eGFR of -10.5 ml/min/1.73m² was found in both 
intervention and non-intervention groups. Both groups also had a decrease in eGFR over the harvest, 
although somewhat lower in the intervention group, -3.4 ml/min/1.73m² compared to -5.3 
ml/min/1.73m² in the non-intervention group, suggesting that intervention may reduce the eGFR 
decline. Most likely a longer intervention time than 2-3 months is needed to study the long-term 
effects of the intervention on renal function and the development of chronic kidney injury.  
6.1.1 Uric acid / fructokinase / dehydration mechanism hypothesis 
Roncal-Jimenez and co-workers argue that MeN might be a uric acid disorder (133). Since uric acid 
can develop during heat stress due to muscle cell damage, and because workers exposed to 
occupational heat stress with the risk of volume depletion probably develop increased urinary 
concentration, the authors hypothesized that sugarcane workers might be subjected to repeated 
uricosuria with the formation of urate crystals causing tubular damage and hyperuricemia causing 
glomerular hypertension. The authors refer to a pilot study of sugarcane workers in which uric acid 
crystals were common findings in the urine samples. The data from the original study of sugarcane 
workers by Garcia-Trabanino et al 2015 (44) showed that serum uric acid levels were elevated (>7.0 
mg/dl) in 26% of sugarcane workers before a work shift and in 43% after the work shift compared to 
serum creatinine which was increased in 20% of the workers pre-shift and in 25% of the workers post-
shift. Interestingly, urine samples from the same workers demonstrated the presence of urate crystals 
in 16% of the pre-shift samples and in 22% in the post-shift samples. Another study of sugarcane 
workers by Wesseling et al showed that uric acid in serum did not change significantly during the 
workday, even though the urine uric acid increased significantly during the workday (43). Kupferman 
reported in 2016 that serum uric acid levels where higher in MeN patients compared to CKD 
participants in a large US cohort (NHANES); however, the two cohorts were very different in age 
composition, and when comparing men ≤65 years of age there was no statistical difference in uric acid 
levels (37). Whether hyperuricemia per se might cause or worsen kidney damage has been heavily 
debated (134).  
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A possible mechanism behind dehydration-induced kidney damage involving fructose metabolism and 
uric acid has been proposed in an animal study conducted by Jimenez and colleagues. In that study, 
both fructokinase-knockout mice and wild-type mice were exposed to repetitive dehydration by 
placing the mice in a warm chamber. Some mice had access to water during the entire day, and some 
mice only received water at night after suffering dehydration during the day. Renal injury markers 
(serum creatinine, urinary NGAL and renal tissue findings of tubule-interstitial damage) were 
increased in the wild-type mice that received water only at night, while the fructokinase-deficient mice 
with delayed rehydration did not show any renal damage. The authors suggested the pathological 
mechanism to be injury to the tubuli caused by end products in fructose metabolism (uric acid, 
inflammatory mediators, and oxidants) (135). 
In Studies I, II, and III the uric acid levels were above the reference value of 416 µmol/L (7.0 mg/dl) 
in 75%, 58%, and 55% of the participants, respectively. None of the participants had values over 715 
µmol/L. In one patient from Study II (Nicaragua), uric acid crystals were found in the urine, but none 
of the other patients included in Studies I, II, and III had urine crystals reported. The urine uric acid 
levels were measured in all three studies and were within the normal range. When evaluating the renal 
biopsies, there were no signs of chronic urate crystal depositions, such as microtophi formation or 
granulomas, surrounding giant cells, or scars indicating prior granulomas. Furthermore, no feathery or 
needle shaped crystals were found, nor any empty spaces indicating dissolved crystals (136, 137). 
Thus the results from our three studies do not support the uric acid hypothesis because, we did not find 
any typical acute or chronic uric acid deposits in the kidney tissue. Uric acid levels in serum were 
typical of what is to be expected in patients with CKD. Nevertheless, it should be noted that our 
samples were all collected outside of harvest season, i.e. not during periods of occupational heat stress 
when uric acid crystals in urine has been reported to be found in sugarcane workers (133), which 
limits the interpretation of our samples in relation to the hypothesis. 
 
6.2  PESTICIDES 
Although exposure to various pesticides has been reported to cause damage to a number of different 
organ systems, AKI from pesticides is mainly seen in connection to severe systemic toxicity (138).  
In both the Central American and Sri Lankan CKDu endemics, pesticides have been proposed as 
possible contributing factors. Several studies including cross-sectional, case-control and case studies 
have examined pesticide exposure mainly by self-reported exposure in questionnaires and with 
varying assessment of exposure (often yes or no). To my knowledge, the only longitudinal study (with 
6 months follow-up) of pesticide exposure is that published by Laws et al (as described below).   
Most studies from Central America have not found an association between pesticides and CKD. 
Gracia et al, studied 297 men living in coastal areas of El Salvador and found that 13% of the 
participants had CKD (29). The authors reported that being a farmer, pesticide exposure, and alcohol 
consumption were common characteristics in participants both with and without CKD, thus not 
supporting an association between CKD and pesticides (29). A cross-sectional study from Nicaragua 
by Sanoff et al included 124 CKD cases and 873 participants without CKD and showed that self-
reported pesticide exposure was significantly associated with CKD in a univariate analysis, but not in 
a multivariable analysis (34). In Nicaragua, Laux et al (36) measured renal function among 267 
inhabitants aged 20-60 years in a coffee growing village located 1000 meters above sea level. The 
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prevalence of reduced eGFR (<60 ml/min/1.73m²) was <1% in this farming community, although 
98% of the male participants reported exposure to pesticides (either preparing or applying pesticides), 
suggesting that high pesticide exposure is not correlated to decreased kidney function. Laws et al 
followed a cohort of 284 sugarcane workers during harvest season and found that pesticide applicators 
did not have a significant decrease in eGFR during harvest period, while sugarcane workers with other 
tasks (seed cutters and irrigators) did have a significant decrease in eGFR. Furthermore, the urinary 
biomarkers NGAL and IL-8 did not increase during harvest among pesticide applicators (p=0.9), but 
they rose significantly in cane cutters, seed cutters and irrigators forking in the same sugarcane fields 
(41, 42).  
In contrast to these studies, there are also some reports from Central America of a significant 
association with pesticides. For example, Raines et al (2014) reported from a cross-sectional study of 
424 individuals in Nicaragua, that non-deliberate pesticide inhalation was a risk factor for CKD (age 
and sex-adjusted OR 3.14, 95% CI 1.12-8.78); however ,other indicators of pesticide exposure such as 
“lifetime days mixing pesticides”, “lifetime days applying pesticides”, and “lifetime days working in 
fields with pesticide use” were not different between CKD cases and non-CKD participants (19). 
Garcia-Trabanino et al found that among 189 sugarcane cutters in El Salvador, carbamate pesticide 
use was more frequent among sugarcane workers with CKD compared to workers without CKD (74% 
vs 29%). Furthermore, in a logistic regression model “any use of pesticides ever” was not associated 
with CKD, but if replaced with “use of carbamate pesticides ever” in the model a significant 
association was found (44). 
In Sri Lanka, pesticides as a possible cause for the CKDu endemic has been heavily debated, and a 
number of studies of varying quality have been performed. In a case-control study by Wanigasuriya et 
al (2007), including 138 CKDu cases and 200 controls, the initial analysis indicated that the use of 
pesticides was a risk factor for CKDu, but in multivariate logistic regression analysis no association 
was found (59). Athuralia et al, studied 246 patients with proteinuric CKD in three different regions, 
including one CKDu endemic region and two non-endemic regions. In a multiple logistic regression 
model adjusted for hypertension and diabetes mellitus, agrochemical exposure was only found to be a 
significant predictor of CKD in one of the non-endemic regions (53).  
Jayasumana et al have argued for the hypothesis that a combination of the pesticide glyphosate, hard 
water and nephrotoxic metals might be the cause for the CKDu endemic in Sri Lanka. The authors’ 
arguments are mostly based on the geographical distribution of water hardness in ground water and 
the prevalence of CKDu, and they hypothesize that a glyphosate and metal complex causes the kidney 
damage (139). A case-control study by the same author was published in 2015, comparing risk factors 
among 125 CKDu cases and 180 controls using questionnaires. In addition, drinking water was 
analyzed for metals, hardness, and glyphosate. Using a multivariable analysis, the study showed that 
risk factors for CKDu were drinking water from abandoned wells (OR 2.52, 95% CI 1.12-5.70), a 
history of drinking water from abandoned wells (OR 5.43, 95% CI 2.88-10.26), and using the 
pesticide glyphosate (OR 5.12, 95% CI 2.33-11.26). Analysis of water from abandoned wells showed 
higher levels of glyphosate and more hardness compared to other water sources, but glyphosate levels 
were far below the no-observed-adverse-effect levels used in animal models (140). Even though this 
study to some extent supports Jayasumana´s hypothesis, there is, as of yet, no clear evidence for the 
prevalence or nephrotoxicity of this glyphosate-metal complex.  
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In Sri Lanka, Jayatilake et al (57) found residues of seven different pesticides, of the eleven measured 
in urine samples from CKDu patients in Sri Lanka. However, because the authors did not report the 
levels of pesticide residues in controls these findings are almost impossible to interpret.  
A detailed review of 21 published articles (11 from Central America, 5 from Sri Lanka, and 6 from 
other countries) related to pesticide exposure and CKDu endemics concluded that there is very scarce 
evidence for an association between CKDu and pesticide exposure (141). Thirteen studies showed a 
positive association and eight studies showed no association between CKDu and pesticide exposure.  
However, most articles were considered to be of low or medium explanatory scientific value due to 
study design, unspecific and/or unquantified pesticide exposure, confounding factors and selection 
bias. Even though the authors of the review concluded that the evidence is insufficient, they called for 
further studies with better design and assessment of specific pesticide exposure and interactions with 
other risk factors such as heat stress before fully discarding the possible involvement of pesticides in 
CKDu development.  
A recent publication by Lebov et al (2016) studied the association between work related exposure to 
39 pesticides and ESRD among a cohort of 55580 male pesticide applicators in Iowa and North 
Carolina in the US. Three hundred twenty individuals in the cohort who were diagnosed with ESRD 
during a 14-18 year follow-up answered self-administered questionnaires regarding pesticide usage. A 
large number of statistical associations were examined, but only a few showed statistical significance. 
Positive dose-related associations were reported for six pesticides: alachlor, atrazine, metolachlor, 
paraquat, and pendimethalin and the permethrin. Hospital stay due to pesticide use (HR 3.05, 95% CI 
1.67-5.58) and multiple medical visits after pesticide use (HR 2.13, 95% CI 1.17-3.89) were also 
found to be associated with ESRD (142).  
In summary, the evidence for pesticides contributing to the CKDu endemics in Central America and 
Sri Lanka is weak, and even though, an association has been observed in some studies, the alleged 
compounds differ between the studies, which challenges a joint etiology. One can also argue that if 
pesticides were to cause permanent kidney damage, other organ systems would probably also be 
affected, but this is not a common feature in MeN or CKDu in Sri Lanka. However, as Wesseling and 
co-authors have stated, the available studies are not of satisfying quality and better studies, preferably 
with better life-time pesticide exposure assessments and, if possible, longitudinal studies, are 
warranted.    
 
6.3  HEAVY METALS 
The measurement of urine heavy metals is often performed to evaluate the extent of heavy metal 
exposure. However, urine samples might not reflect the lifetime exposure of inorganic compounds 
even though some compounds, including urinary cadmium, have been proposed to be correlated with 
the accumulation of cadmium in kidney tissue (143). Nevertheless, urinary metals are frequently 
analyzed to assess heavy metal levels in exposed individuals, and these give a relatively accurate 
reflection of the current exposure. When evaluating urinary heavy metal levels it is important to know 
that in patients with impaired kidney function, urinary creatinine-adjusted values may be misleading 
due to a lower clearance of creatinine. 
Urine heavy metals were all of non-toxic levels in Studies II and III, thus not supporting the 
hypothesis that heavy metal exposure is involved in the pathogenesis of CKDu in Central America or 
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Sri Lanka, although it must be noted that the study samples were small. Urine heavy metals have also 
been measured in other studies from both regions. In Sri Lanka, the debate regarding heavy metals has 
been more intense, and many researchers in the area are studying if there is an association to CKDu, 
but so far these studies have provided varying and contradictory results (50, 144).  
In one study from Sri Lanka by Jayasumana et al, 19 different heavy metals and the pesticide 
glyphosate were analyzed in urine samples from 10 patients with CKDu from one endemic region, 10 
controls from the same endemic region and 10 controls from non-endemic areas. The study found that 
median urinary levels (µg/L) of 18 of the 19 heavy metals and glyphosate were highest in the endemic 
control-group. When adjusted for urine creatinine (µg/g), 15 of the 19 heavy metals and glyphosate 
were higher in the CKDu patients. In the control group from the non-endemic areas, the urinary heavy 
metal levels and glyphosate levels were generally lower (145). Compared to our heavy metal analysis 
in Study II, the levels reported in the study by Jayasumana are substantially higher, both in cases and 
controls, including cadmium, lead and vanadium, indicating that the high levels might be a locally 
occurring problem. Another study from Sri Lanka, evaluating urinary heavy metals among CKDu 
cases (n=311) and controls (n=286), reported that all of the 18 measured heavy metal levels (µg/L) 
were higher in controls than in CKDu cases. When adjusting for urine creatinine, Al, As, Co, Cu, Mn, 
and Zn (µg/g creatinine) were significantly higher in cases than controls; however, cadmium levels 
were significantly higher in controls (60).  
Arsenic:  
Arsenic is found in both a highly toxic inorganic form and a non-toxic organic form. The organic form 
is common in fish and seafood and thus diets high in these foods increases the total amount of arsenic 
in urine, without influencing the toxicity. Even though inorganic arsenic might cause severe systemic 
toxicity, kidney damage has rarely been reported (73).  
In Sri Lanka, arsenic levels were measured in urine and hair samples in 125 CKDu cases and 180 
controls by Jayasumana et al. They reported that 68% of the CKDu patients had total urine arsenic 
levels of >21 μg/g creatinine, compared to 28% in controls, and they suggested that arsenic might be 
of importance in the pathogenesis of CKDu (146). However, the differences could be due to different 
diets in the two groups. Another study of urine arsenic in CKDu patients (n=495) and controls, 
showed no significant difference in arsenic levels (57). In Studies II (Nicaragua) and III (Sri Lanka), 
the mean urinary arsenic levels were 10 µg/L (12 µg/g creatinine) and 37 µg/L (42 µg/g creatinine), 
respectively, which is moderately higher than in the US population (8.3 µg/g creatinine)(147), but 
slightly lower compared to levels in a Korean cohort (41 µg/g creatinine)(148). Furthermore, all 
samples in Studies I and II and the values reported by Jayasumana et al (146) were within what is 
considered a normal range, i.e. <100µg/L (149). Furthermore, in a study by Nanayakkara et al specific 
arsenic levels were measured in CKDu patients and controls, showing that there was no significant 
difference between groups (60). Taken together, arsenic is not likely to be an important factor in 
CKDu in Central America or Sri Lanka.  
Cadmium: 
Cadmium can cause kidney damage characterized by tubular proteinuria and may develop or 
contribute to decreasing kidney function (75). In Sri Lanka, one of the first hypotheses regarding 
CKDu etiology was cadmium exposure. Bandara et al reported high levels cadmium in water, fish and 
plants in endemic areas as well as high urinary cadmium levels (7-11µg/g creatinine) from both CKD 
 46 
 
patients and controls without CKD (150). However, these values were later proven to be incorrect 
when two other studies showed that urine cadmium levels were actually about ten times lower in 
CKDu patients (the mean urinary cadmium levels were 0.79 and 0.32-0.67 µg/g creatinine 
respectively) (54, 61), which corresponds well to the cadmium levels found in Study III (mean 0.49 
µg/g creatinine). These levels are non-toxic (143), thus not supporting a role of cadmium in the 
development of CKDu in Sri Lanka. Cadmium levels have also been rejected as a possible causative 
factor in Central America because measurements from sugarcane workers in endemic regions were 
generally equivalent to the levels found in the US population (49). In our study from Nicaragua (Study 
II), we could confirm this finding, since our observed urinary cadmium levels were low (0.1 µg/g 
creatinine). 
Lead: 
Low levels of lead have been reported from MeN patients in Central America and without association 
with renal function (35). In Studies I and II, low, or even unmeasurable levels, of lead were found in 
urine samples. Contradictory results, i.e. both high and low/normal urinary levels have been reported 
from Sri Lanka (60, 145). The typical morphological finding of intranuclear lead inclusion bodies (72) 
was not observed in our three studies, nor have they been reported in renal biopsies from other MeN 
or CKDu cases (53, 101). 
Mercury: 
Mercury-induced kidney damage typically causes nephrotic syndrome with membranous nephropathy 
as the classic morphological lesion (78). The clinical picture of CKDu in Central America and Sri 
Lanka, with no or low-range proteinuria suggests that the risk of mercury-induced kidney damage is 
low. Furthermore, urinary mercury levels in Studies I and II were low or even below detection levels.  
In summary, there is very scarce evidence for heavy metals as a contributing factor in CKDu, and the 
available studies measuring urinary levels report contradictory results. In addition, the morphological 
picture described in our studies and described in other biopsy studies does not correspond to the 
typical findings described in heavy meta- induced nephropathy.  
 
6.4 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) 
NSAIDs are available over the counter in many rural supermarkets in Central America, and their use 
has been described as high in areas with MeN, especially in El Salvador. Local physicians and 
pharmacists have reported that inhabitants involved in agriculture frequently use NSAIDs due to 
muscle ache or “chistata” (47). In a cross-sectional study of 976 men and 1412 women in an area in El 
Salvador with a high prevalence of CKD, 84% of the included participants reported use of NSAIDs 
(23). Two other studies in El Salvador reported that >70% of both CKD cases and controls and 41% 
of CKD patients used NSAIDs respectively (19, 45). In our studies in Central America, we could 
observe this pattern of NSAID use in some of our patients. In Study I, five of the eight participants 
reported weekly use of NSAIDs even though they were known CKD patients with regular visits to a 
renal clinic (112), and in Study II six of the 19 patients (32%) reported that they had used NSAIDs on 
a weekly basis for ≥2 years (151). However, the majority of the participants did not report NSAID 
use. Quite contrary to our findings in Central America, in Study III in Sri Lanka, none of the 
participants reported any NSAID usage (152). 
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NSAIDs can cause kidney injury through drug-induced/allergic acute tubulointerstitial nephritis, 
which is characterized by tubulitis, interstitial edema, and interstitial inflammation containing 
eosinophils. In our three studies, none of the renal biopsy specimens displayed such a morphology. 
Nevertheless, NSAIDs can also affect the kidney by inhibiting the production of prostaglandins, 
which are important substances to increase renal blood flow by dilatation of afferent renal arterioles. 
The prostaglandins’ abilities to increase or maintain renal blood flow is especially important under 
conditions of decreased renal perfusion, such as hypotension and decreased renal arterial blood flow 
(153). It is well known that NSAIDs can cause or contribute to AKI under conditions of hypotension. 
Intake of NSAIDs in combination with decreased renal blood flow (e.g. dehydration/volume depletion 
secondary to work related heat stress) might contribute to the signs of glomerular ischemia seen in our 
patients from Central America (Studies I and II). However, since not all participants in our studies 
reported use of NSAIDs, this seems very unlikely to be the main cause behind the disease. 
Nevertheless patients diagnosed with MeN or CKDu should avoid NSAIDs and sugarcane workers, 
and other individuals with heavy physical occupations in hot environments, should probably also 
avoid NSAID use, at least before and during heat stress exposure.   
 
6.5  INFECTIONS 
Infectious etiologies have been proposed in CKDu both in Central America and Sri Lanka (154, 155), 
but no specific pathogen has yet been found to have a role in the pathogenesis. Urine cultures from 
sugarcane workers both with, and without, dysuria or “Chistata” symptoms have been negative in 
several studies (49, 156). In our three studies, urine cultures were negative in all but one patient (Study 
I, E.coli), indicating that urine infections due to bacteria are rare. Leptospirosis has been suggested to 
be a possible pathogen involved in the development of CKDu, although it has not yet been proven to 
cause CKD in humans (15). Because CKDu cases are often asymptomatic, while leptospirosis 
infection causes rather severe symptoms (flu-like symptoms, jaundice, hemorrhage, renal failure, and 
myocarditis), a causative connection seems unlikely, but needs to be further investigated.  
Hantavirus is a common pathogen in rural areas in Sri Lanka and a recent publication reported that 
>50% of patients with CKDu were found to be seropositive for Hantavirus (14% in controls) (157). In 
Study III we performed serological tests for both leptospirosis and Hantavirus because interstitial 
inflammation was more severe in renal biopsies in some cases. The tests were actually positive for 
Hantaan virus (IgG positive, IgM negative) in eight of eleven patients, indicating a previous infection. 
Since our patients did not report any hospitalizations or treatments for hantavirus-associated 
hemorrhagic fever with renal syndrome (acute tubulointerstitial nephritis) or cardiopulmonary 
syndrome, a subclinical or mild infection could have been the case in our patients. As of yet, there are 
no reports that a mild or subclinical Hantavirus infection could cause kidney damage, but a few 
reports indicate a higher prevalence of Hantavirus antibodies in renal failure cohorts (158, 159). Data 
regarding Hantavirus prevalence in Central America is scarce (160), but to date there is no evidence 
for Hantavirus involvement in CKDu in Central America. Investigation of serum prevalence of 
Hantavirus antibodies in MeN would be interesting. Even if Hantavirus itself might not be the primary 
etiology behind CKDu, one could speculate whether patients with a previous Hantavirus or other 
potential infection might be more vulnerable and susceptible to other types of kidney damage, 
including CKDu.    
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6.6  GENETIC FACTORS 
Although a family history of CKD has been shown to be a risk factor in both Central America and Sri 
Lanka (22, 59), this increased risk might be explained by the fact that families tend to live in the same 
region and have the same profession as their parents. In a study from Sri Lanka, 10 patients with a 
familial clustering of CKDu were found in a cohort of 106 patients. When studying pedigrees, no 
evidence was found for autosomal dominant or recessive inheritance, nor for X-linked inheritance (61). 
However, genetic susceptibility may be of importance since both Brazil and Cuba, do not have 
increasing rates of CKDu even though they produce sugarcane with the same technique and have a 
similar climate.  
One study supporting genetic susceptibility was published by Nanayakkara et al. They performed a 
genome-wide association study on whole blood DNA from 311 CKDu cases and 286 controls from 
CKDu endemic areas in Sri Lanka. They found a single-nucleotide polymorphism (SNP), rs6066043 
close to the SLC13A3 gene that was significantly associated with CKDu, and the population 
attributable fraction/risk was 50% with an odds ratio of 2.13. The SLC13A3 gene encodes “high-
affinity sodium dicarboxylate transporter 3”, a protein found in the basolateral membranes of renal 
proximal tubules, but also in the brain, liver, and placenta. Although these novel findings are 
interesting, further studies are needed to establish if there is indeed a link between SNP rs6066043 and 
CKDu.  
To our knowledge, no genetic studies have been performed regarding MeN/CKDu in Central 
America. 
 
7 SUMMARY AND CONCLUDING REMARKS 
The three studies included in this thesis have provided detailed information regarding renal 
morphology in the CKDu endemics in Central America and Sri Lanka. Study I was the first study to 
show that Mesoamerican nephropathy has a unique morphology and thus constitutes a new diagnostic 
entity. Study II could confirm the morphological findings in patients from a different region in Central 
America, and the results from Study III indicate that the disease might affect other regions. 
Furthermore, the clinical and biochemical characteristics reported in the studies have provided 
important information that can be used in the clinical evaluation process as well as for ongoing and 
future research regarding the etiology and pathophysiology behind the disease. 
The morphological, biochemical, and clinical data from our three studies do not resemble any 
previously described endemic nephropathy such as Balkan nephropathy/aristolochic acid nephropathy 
or heavy metal-induced nephropathy. Aristolochic acid nephropathy is also correlated to an increased 
risk of urothelial cancer (68), something that has not been observed in CKDu regions. Even though the 
use of herbal remedies is relatively common in Central America and Sri Lanka, aristolochic acid is not 
a common ingredient in Central American remedies. In Sri Lanka, aristolochia species in traditional 
Ayurvedic treatments are rarely used, and if used the doses are negligible (161). 
In Study I, the findings of low sodium and potassium were quite surprising, and Study I was actually 
the first report on this phenomenon. Several subsequent studies have been able to confirm that these 
changes are present in other MeN cohorts. We have speculated whether the low levels of sodium 
and/or potassium could have a role in the pathogenesis, because changes in these substances might 
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stimulate hormonal systems, e.g. RAAS, vasopressin, etc. The morphological findings in Studies I and 
II, and to some extent also Study III, with glomerular ischemia and a mix of chronic glomerular and 
tubulointerstitial changes, might support the hypothesis of recurrent volume depletion, causing direct 
glomerular and tubulointerstitial damage as well as secondary damage through RAAS activation and 
constriction of glomerular arterioles. However, all three studies were of descriptive design and cannot, 
as of yet, provide strong evidence for this hypothesis.  
Low serum magnesium was the most common electrolyte disturbance in our three studies and might 
be partly responsible for the low potassium levels, since concomitant hypomagnesemia is known to 
aggravate hypokalemia (162).  
One of the most interesting observations in our studies was the urinary findings in the participants 
with low serum levels of sodium, potassium, and magnesium, which indicates that renal wasting of 
these compounds is likely to be a main reason behind the low serum levels. An explanation for the 
renal losses could be chronic tubulointerstitial damage. In support of this hypothesis, Wesseling et al 
(43) found that serum potassium was significantly lower in sugarcane workers after 9 weeks of 
harvest compared to potassium at the start of the harvest, even though serum creatinine increased 
during this period. In the same cohort, the urinary tubular injury marker NGAL also increased 
significantly, supporting the hypothesis that the tubular injury might be responsible for the drop in 
serum potassium level. One could also speculate whether the high output of electrolytes could have a 
role in the pathophysiology of CKDu, probably will it make patients more susceptible to volume- and 
further salt depletion.  
Hypokalemic nephropathy is a diagnosis mostly found in old scientific literature and is described as a 
chronic interstitial nephritis seen in patients with chronic hypokalemia (163). Findings in renal 
biopsies are swelling and vacuolization of the proximal tubular epithelium, tubular dilatation and 
atrophy, but with normal glomerular structures (164). Even though hypokalemic nephropathy in 
humans nowadays rarely is described in the scientific literature, several animal studies, where the 
dietary intake of potassium can be limited, have described hypokalemic nephropathy and suggest that 
chronic hypokalemia induces renal vasoconstriction, renal ischemia, and progressive interstitial 
fibrosis (165, 166). The morphological pattern in our studies does not resemble the findings reported 
from human hypokalemic nephropathy, because our patients had pronounced glomerular damage. 
However, one might speculate whether the chronic serum depletions of potassium seen in a subset of 
our patients could have a role in the pathophysiology and deterioration of kidney function.    
The natural history of the disease has not been sufficiently described in Sri Lanka or in Central 
America. Study II was the first longitudinal report of the natural history of the disease and showed 
that, on average, eGFR deteriorated by 4.4 ml/min/1.73m² per year, but in some cases eGFR was 
stable or even increased. Even though our follow-up study was small, these findings suggest that not 
all affected patients have a rapid disease progression of the disease. Data from our study also indicated 
that patients with low serum sodium and severe glomerular hypertrophy might have faster 
deterioration of kidney function. Further studies in larger cohorts are needed to study the natural 
history of the disease, which is of great importance for identify risk factors for deteriorating kidney 
function as well as for suggesting which clinical findings indicate a worse prognosis so that patients at 
higher risk can be identified and more closely monitored.  
In my opinion, the available studies from the CKDu endemic in Sri Lanka have, as of yet, not 
sufficiently described the characteristics of the endemic. Well-designed epidemiological studies using 
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screening for increased serum creatinine in combination with urine dip-stick would give a better 
perspective of the true prevalence of CKDu in Sri Lanka. Clinical case descriptions of larger cohorts, 
including detailed blood and urine testing, are needed to give a more comprehensive picture of the 
typical CKDu patient in Sri Lanka. Data from our study in Sri Lanka suggest that electrolytes both in 
serum and urine should be included in such studies, in combination with a broader testing panel of 
blood and urine characteristics, similar to what we have used in our studies. More comprehensive 
epidemiological and clinical studies would surely give important insights regarding etiology and 
would also provide more evidence for whether the endemics in Sri Lanka and Central America truly 
have a common etiology or not.  
Even though it is not established that any nephrotoxic compound in the water has any role in the 
pathophysiology of CKDu in Sri Lanka and Central America, providing clean water to individuals 
living and working in a warm climate is of course important. If there are any potential nephrotoxic 
substances in the water, these will then be reduced, which will be overall beneficial for individuals 
with CKD.    
Interestingly, two recent separate reports, one from a sugarcane mill based hospital in Nicaragua (167) 
and the other from Sri Lanka (66), describes findings of “acute” CKDu, defined as an acute illness, 
where the patient present at the hospital with diffuse inflammatory symptoms (e.g. back pain, feverish 
fatigue, nausea, etc.) and elevated creatinine levels. Clinically the patients often have increased 
inflammatory parameters in the both blood and urine. In the study from Sri Lanka, renal biopsies were 
collected and indicated acute interstitial nephritis. From Nicaragua there are no published biopsy 
findings, but preliminary findings from 11 patients showed interstitial nephritis (abstract) (168). The 
patients in our studies did not report any acute inflammatory illnesses in conjunction with increases in 
serum creatinine. However, some of the sugarcane workers in Study II have reported that they had 
been treated for work-related heat symptoms/exhaustion at the sugar mill hospital, but we did not have 
access to their medical records (personal communication, Marvin González-Quiroz). An interesting 
hypothesis is whether heat stress or heat stroke can cause episodes of systemic inflammation that also 
affects the kidneys. One might also suspect an unknown infectious pathogen, and thus further studies 
are warranted in this field in both regions.   
From our three studies we can conclude that there are many similarities between the two CKDu 
endemics in Central America and Sri Lanka, but also some differences. The main difference in 
morphology is the more heterogeneous picture in Sri Lanka, even though more than half of the 
patients had a morphology very similar to the CKDu findings in Central America. One cannot 
completely rule out different etiologies of CKDu in Central America and Sri Lanka; however, they 
probably have a similar pathophysiological mechanism since both the clinical picture, the biochemical 
findings, and the renal morphologies have so many resemblances.   
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8 FUTURE PERSPECTIVES  
Even though the knowledge about CKDu in Central America and Sri Lanka has increased 
significantly during the last ten years, there are still numerous of unresolved questions about the 
etiology, pathogenesis, and natural history of the disease(s).  
One of the most interesting findings in our studies is the low serum electrolytes levels of sodium, 
potassium and magnesium and the signs of renal wasting of these compounds in the urine. Further 
studies of the urinary biochemical profile in CKDu patients are warranted and, in my opinion also 
more in-depth studies of the tubular system including tubular ion-channels involved in the transport of 
these electrolytes. Moreover, the role of electrolyte depletion in patients with MeN/CKDu and the 
importance in the pathogenesis should be further studied. One can hypothesize that low levels of 
sodium, potassium, and/or magnesium with, or without concurrent volume depletion, may affect 
different hormonal systems such as the RAAS or vasopressin/antidiuretic hormone (ADH). Activation 
of these pathways may be responsible for some of the chronic damages seen in the kidneys. In future 
studies, it would be interesting to measure different RAAS components and ADH in an occupational 
setting with heat exposure.  
Our studies support a common etiology of the two endemics, but larger studies examining both kidney 
biopsies and blood and urine characteristics are needed to confirm this. As discussed previously, the 
epidemiological and clinical profile of the CKDu endemic in Sri Lanka need to be better described, 
especially the prevalence of CKD by measurement of serum creatinine and eGFR in epidemiological 
studies. A better description would give more information regarding resemblances with the CKDu 
endemic in Central America and also provide more knowledge about risk factors for CKDu in Sri 
Lanka. Another way to compare the two endemics would be to analyze the transcriptome, i.e. RNA 
profiles, in the kidney tissue. Matching or similar profiles would further support a common etiology. 
Transcriptome analysis provides information on which genes that are up or down regulated in the 
tissue cells and may provide valuable information regarding the pathogenesis and etiology of the 
disease.  
Another important step is to evaluate possible endemics of CKDu in other regions. One interesting 
region where a high prevalence of CKD has been reported is India, and especially rural areas in the 
Andhra Pradesh region. Published studies from this region are largely lacking and therefore well-
designed epidemiological and clinical studies from this region would be of great interest. Since our 
studies support that the two CKDu endemics in Central America and Sri Lanka are similar diagnostic 
entities, studies of other CKDu endemics around the world would most certainly provide important 
information regarding etiologies and risk factors. If the cause behind CKDu is a specific exposure, 
similar exposure is likely to be found in all endemic areas. Thus, if the disease is found in professions 
involving physically strenuous work in more tropical or sub-tropical regions this would support the 
occupational heat stress hypothesis. In this context the current and future contributing effect of global 
warming should also be further addressed.  
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Bakgrund: Kronisk njursvikt, d.v.s. permanent nedsatt njurfunktion, är ett globalt hälsoproblem. De 
vanligaste bakomliggande orsakerna till kronisk njursvikt är diabetes, högt blodtryck och kronisk 
njurinflammation. Under de senaste årtiondena har förekomsten av kronisk njursvikt av okänd orsak 
(CKDu) ökat kraftigt på landsbygden i vissa tropiska områden, bland annat i Centralamerika och på 
Sri Lanka. Gemensamt för de utbrott av CKDu som rapporterats är att de oftare drabbar män än 
kvinnor och att CKDu i huvudsak ses hos landsbygdsbefolkning. I Centralamerika drabbas främst 
män som skördar sockerrör medan det i Sri Lanka främst är manliga risodlare som insjuknar. Den 
underliggande orsaken eller orsakerna till CKDu har ännu inte klarlagts, men i Centralamerika har 
man kunnat fastställa att hårt fysiskt arbete i varmt klimat med risk för upprepad intorkning är en 
riskfaktor. Det är fortfarande oklart om det rör sig om samma sjukdomstillstånd eller om det är olika 
sjukdomar i Centralamerika respektive Sri Lanka. Vävnadsprov från njurarna, så kallade njurbiopsier, 
är ett viktigt redskap för att undersöka orsakerna till kronisk njursvikt, vilket genomförs rutinmässigt 
vid utredning av kronisk njursvikt i Sverige och andra länder med utvecklad sjukvård. I 
Centralamerika hade inga studier av njurbiopsier från patienter med CKDu genomförts när detta 
projekt startade.  
Mål: Målet med studierna i denna avhandling var att beskriva vilka förändringar som kan ses i 
njurbiopsier samt i blod och urinprover hos patienter med CKDu i Centralamerika och Sri Lanka. 
Detta är av avgörande betydelse för att kunna förstå orsaken till och i förlängningen kunna förebygga 
sjukdom. Vi ville också studera sjukdomsförloppet samt jämföra CKDu i dessa länder för att kunna 
klarlägga om det är samma sjukdom.    
Material och metoder: Studierna planerades och genomfördes i samarbete med lokala läkare och 
forskare. Tillstånd från etiska kommittéer inhämtades både i Sverige och i samarbetsländerna och alla 
patienter samtyckte till att delta i studierna. Njurbiopsier, blod och urinprover insamlades från 
patienter med njursvikt av okänd orsak. Deltagarna fick även fylla i ett frågeformulär om 
sjukdomshistoria, medicinering, livsstilsfaktorer mm. Ljus- och elektronmikroskopi användes för att 
utvärdera biopsierna. Uppföljningsprover insamlades från patienterna i Studie I och II efter 1-2,5 år.  
Studie I: Åtta manliga jordbruksarbetare i El Salvador med mild till måttligt nedsatt njurfunktion 
(uppskattad glomerulär filtrationshastighet (eGFR) mellan 27-79 ml/min/1,73m2) och utan känd orsak 
till sin nedsatta njurfunktion, d.v.s. CKDu, inkluderades i studien. Njurbiopsierna visade en unik bild 
med omfattande ärromvandling av njurens kärlnystan (glomeruloskleros), tecken på försämrat 
blodflöde i njurens kärlnystan (glomerulär ischemi) samt milda till måttliga kroniska skador på 
njurens rörsystem och bindvävsomvandling av njurvävnaden (tubulär atrofi och interstitiell fibros). 
Blodkärlen i njurvävnaden var oftast normala eller uppvisade lättare förändringar. Blodproverna 
uppvisade låga nivåer av saltet kalium hos flertalet av patienterna.   
Studie II: Nitton män från Nicaragua med misstänkt CKDu som arbetat på sockerplantager 
inkluderades i studien. Njurfunktionen var mild till måttligt nedsatt (eGRF mellan 33-96 
ml/min/1,732) och låga halter av natrium, kalium och magnesium i blodet var vanliga fynd. Sexton 
njurbiopsier var av tillräckligt god kvalitet för att ingå i studien. De visade kroniska förändringar på 
njurens kärlnystan med ärromvandling (glomeruloskleros), förstorade kärlnystan (glomerulär 
hypertrofi) och tecken på försämrat blodflöde (glomerulär ischemi). Milda till måttliga kroniska 
skador på njurens rörsystem och bindvävsomvandling av njurvävnaden (tubulointerstitiella 
förändringar) samt milda förändringar i njurens blodkärl observerades. Uppföljningsprover från 7 
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studiedeltagare från Studie I och 18 studiedeltagare från Studie II visade att den genomsnittliga 
försämringen av njurfunktionen som mäts med eGRF var 4.4 ± 8.4 ml/min/1,73m² per år.  
Studie III: Elva risbönder från Sri Lanka med mild till uttalat nedsatt njurfunktion (eGRF mellan 21-
70 ml/min/1,73m²) inkluderades i studien. Låga halter av natrium, kalium och magnesium i blod var 
vanliga observationer. De huvudsakliga fynden från biopsierna var kroniska förändringar på njurens 
kärlnystan såsom ärromvandling (glomeruloskleros) förstorade kärlnystan (glomerulär hypertrofi) 
samt milda till måttliga skador på njurens rörsystem och bindvävsomvandling av njurvävnaden 
(tubulär atrofi och interstitiell fibros). Härtill sågs varierande grad av inflammation (interstitiell 
inflammation). Njurens blodkärl hade i de flesta fall endast milda förändringar men var i vissa fall 
måttliga. Njurbiopsierna hos olika patienter uppvisade större variation jämfört med Studie I och II, 
och interstitiell inflammation och kärlförändringar var mer vanligt förekommande.  
Slutsatser: Studie I och II visade att kronisk njursvikt av okänd orsak (CKDu) i Centralamerika är ett 
unikt sjukdomstillstånd med typiska fynd i njurvävnaden som karaktäriseras av kroniska skador på 
både glomerulära och tubulointerstitiella delar. Fynden ger visst stöd för hypotesen att arbetsrelaterad 
värmeexponering med risk för upprepad intorkning är den bakomliggande orsaken, men fortsatt 
forskning är nödvändig för att bevisa detta. Vid jämförelse mellan CKDu i Centralamerika (Studie I 
och II) och Sri Lanka (Studie III) noteras det att biopsifynden i den senare studien hade en mer 
varierad bild, men trots detta uppvisade majoriteten av studiedeltagarna i Sri Lanka liknande fynd som 
i Centralamerika. Låga halter av natrium, kalium och magnesium i blod var vanliga observationer i 
alla tre studierna. Sammantaget tyder resultaten från de tre studierna på att CKDu i Sri Lanka och 
Centralamerika uppvisar fler likheter än olikheter, både vad gäller fynd i njurvävnaden samt i blod och 
urinprover, vilket stödjer hypotesen att de har en gemensam orsak.  
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